Human	B-DNA
interferon	I-DNA
regulatory	I-DNA
factor	I-DNA
2	I-DNA
gene	I-DNA
.	O

Intron-exon	O
organization	O
and	O
functional	O
analysis	O
of	O
5'-flanking	B-DNA
region	I-DNA
.	O

Interferon	B-protein
regulatory	I-protein
factor	I-protein
2	I-protein
(	O
IRF-2	B-protein
)	O
is	O
a	O
transcriptional	B-protein
regulatory	I-protein
protein	I-protein
that	O
terminates	O
interferon	B-protein
beta	I-protein
expression	O
initiated	O
by	O
interferon	B-protein
regulatory	I-protein
factor	I-protein
1	I-protein
.	O

In	O
this	O
study	O
,	O
we	O
isolated	O
the	O
genomic	B-DNA
DNA	I-DNA
for	O
human	B-DNA
IRF-2	I-DNA
gene	I-DNA
,	O
determined	O
the	O
intron-exon	O
structure	O
of	O
the	O
human	B-DNA
IRF-2	I-DNA
gene	I-DNA
,	O
mapped	O
the	O
major	B-DNA
transcription	I-DNA
initiation	I-DNA
site	I-DNA
,	O
identified	O
a	O
number	O
of	O
potential	O
regulatory	O
elements	O
in	O
the	O
5'-flanking	B-DNA
region	I-DNA
,	O
and	O
localized	O
the	O
IRF-2	B-DNA
gene	I-DNA
on	O
human	B-DNA
chromosome	I-DNA
4	I-DNA
.	O

The	O
IRF-2	B-protein
promoter	B-DNA
region	I-DNA
contains	O
a	O
CpG	O
island	O
,	O
with	O
several	O
GC	B-DNA
boxes	I-DNA
,	O
a	O
putative	O
NF-kappa	B-DNA
B-binding	I-DNA
site	I-DNA
,	O
and	O
a	O
CAAT	B-DNA
box	I-DNA
,	O
but	O
no	O
TATA	B-DNA
box	I-DNA
.	O

When	O
the	O
promoter	B-DNA
region	I-DNA
was	O
linked	O
with	O
a	O
heterologous	B-DNA
reporter	I-DNA
gene	I-DNA
,	O
we	O
found	O
that	O
the	O
promoter	B-DNA
region	I-DNA
is	O
inducible	O
by	O
both	O
interferons	B-protein
(	O
interferon-alpha	B-protein
and	I-protein
-gamma	I-protein
)	O
and	O
interferon	B-protein
regulatory	I-protein
factor	I-protein
1	I-protein
.	O

The	O
region	O
which	O
induced	O
these	O
inductions	O
was	O
identified	O
as	O
being	O
confined	O
to	O
40	B-DNA
nucleotides	I-DNA
5	I-DNA
'	I-DNA
to	O
the	O
major	B-DNA
transcriptional	I-DNA
initiation	I-DNA
site	I-DNA
by	O
testing	O
a	O
series	O
of	O
clones	O
with	O
truncated	B-DNA
promoter	I-DNA
of	O
IRF-2	B-protein
.	O

This	O
region	O
contains	O
elements	O
which	O
are	O
shared	O
with	O
the	O
transcriptional	B-DNA
enhancers	I-DNA
of	O
other	O
genes	O
including	O
interferon	B-protein
regulatory	I-protein
factor	I-protein
1	I-protein
,	O
interferon	B-protein
beta	I-protein
,	O
and	O
interferon-inducible	B-DNA
genes	I-DNA
.	O

These	O
data	O
suggest	O
that	O
interferon	B-protein
regulatory	I-protein
factor	I-protein
1	I-protein
not	O
only	O
triggers	O
the	O
activation	O
of	O
the	O
interferon	B-protein
signal	O
transduction	O
pathway	O
,	O
but	O
also	O
may	O
play	O
a	O
role	O
in	O
limiting	O
the	O
duration	O
of	O
this	O
response	O
by	O
activating	O
the	O
transcription	O
of	O
IRF-2	B-protein
.	O

Tus	NULL
Journat	NULL
or	NULL
Brorocicat	NULL
CaEmistay	NULL
©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

7	NULL
,	NULL
Issue	NULL
of	NULL
February	NULL
18	NULL
,	NULL
pp	NULL
.	NULL

5279-5287	NULL
,	NULL
1994	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Human	NULL
Interferon	NULL
Regulatory	NULL
Factor	NULL
2	NULL
Gene	NULL
INTRON-EXON	NULL
ORGANIZATION	NULL
AND	NULL
FUNCTIONAL	NULL
ANALYSIS	NULL
OF	NULL
5-FLANKING	NULL
REGION®*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
May	NULL
26	NULL
,	NULL
1993	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
September	NULL
28	NULL
,	NULL
1993	NULL
)	NULL
Ying	NULL
Cha	NULL
and	NULL
Albert	NULL
B.	NULL
Deisserotht	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Hematology	NULL
,	NULL
the	NULL
University	NULL
of	NULL
Texas	NULL
M.	NULL
D.	NULL
Anderson	NULL
Cancer	NULL
Center	NULL
,	NULL
Houston	NULL
,	NULL
Texas	NULL
77030	NULL
Interferon	NULL
regulatory	NULL
factor	NULL
2	NULL
(	NULL
IRF-2	NULL
)	NULL
is	NULL
a	NULL
transcriptional	NULL
regulatory	NULL
protein	NULL
that	NULL
terminates	NULL
interferon	NULL
B	NULL
expression	NULL
initiated	NULL
by	NULL
interferon	NULL
regulatory	NULL
factor	NULL
1	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
isolated	NULL
the	NULL
genomic	NULL
DNA	NULL
for	NULL
human	NULL
IRF-2	NULL
gene	NULL
,	NULL
determined	NULL
the	NULL
intron-exon	NULL
structure	NULL
of	NULL
the	NULL
human	NULL
IRF-2	NULL
gene	NULL
,	NULL
mapped	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
,	NULL
identified	NULL
a	NULL
number	NULL
of	NULL
potential	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
,	NULL
and	NULL
localized	NULL
the	NULL
IRF-2	NULL
gene	NULL
on	NULL
human	NULL
chromosome	NULL
4	NULL
.	NULL

The	NULL
IRF-2	NULL
promoter	NULL
region	NULL
contains	NULL
a	NULL
CpG	NULL
island	NULL
,	NULL
with	NULL
several	NULL
GC	NULL
boxes	NULL
,	NULL
a	NULL
putative	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
,	NULL
and	NULL
a	NULL
CAAT	NULL
box	NULL
,	NULL
but	NULL
no	NULL
TATA	NULL
box	NULL
.	NULL

When	NULL
the	NULL
promoter	NULL
region	NULL
was	NULL
linked	NULL
with	NULL
a	NULL
heterologous	NULL
reporter	NULL
gene	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
promoter	NULL
region	NULL
is	NULL
inducible	NULL
by	NULL
both	NULL
interferons	NULL
(	NULL
inter-feron-a	NULL
«	NULL
and	NULL
-y	NULL
)	NULL
and	NULL
interferon	NULL
regulatory	NULL
factor	NULL
1	NULL
.	NULL

The	NULL
region	NULL
which	NULL
induced	NULL
these	NULL
inductions	NULL
was	NULL
identified	NULL
as	NULL
being	NULL
confined	NULL
to	NULL
40	NULL
nucleotides	NULL
5	NULL
to	NULL
the	NULL
major	NULL
transcriptional	NULL
initiation	NULL
site	NULL
by	NULL
testing	NULL
a	NULL
series	NULL
of	NULL
clones	NULL
with	NULL
truncated	NULL
promoter	NULL
of	NULL
IRF-2	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
elements	NULL
which	NULL
are	NULL
shared	NULL
with	NULL
the	NULL
transcriptional	NULL
en-hancers	NULL
of	NULL
other	NULL
genes	NULL
including	NULL
interferon	NULL
regulatory	NULL
factor	NULL
1	NULL
,	NULL
interferon	NULL
$	NULL
,	NULL
and	NULL
interferon-inducible	NULL
genes	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
interferon	NULL
regulatory	NULL
factor	NULL
1	NULL
not	NULL
only	NULL
triggers	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
interferon	NULL
signal	NULL
transduction	NULL
pathway	NULL
,	NULL
but	NULL
also	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
limiting	NULL
the	NULL
duration	NULL
of	NULL
this	NULL
response	NULL
by	NULL
activating	NULL
the	NULL
transcription	NULL
of	NULL
IRF-2	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
type	NULL
I	NULL
interferons	NULL
(	NULL
interferon-	NULL
«	NULL
and	NULL
-	NULL
$	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
several	NULL
proteins	NULL
through	NULL
direct	NULL
and	NULL
indirect	NULL
DNA-protein	NULL
and	NULL
protein-protein	NULL
interactions	NULL
(	NULL
Weissmann	NULL
and	NULL
Weber	NULL
,	NULL
1986	NULL
;	NULL
Goodbourn	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Interferon	NULL
regulatory	NULL
factor	NULL
2	NULL
(	NULL
IRF-2	NULL
)	NULL
``	NULL
is	NULL
a	NULL
transcriptional	NULL
regulatory	NULL
protein	NULL
which	NULL
limits	NULL
the	NULL
duration	NULL
of	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
type	NULL
I	NULL
interferon	NULL
genes	NULL
(	NULL
Harada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
1990	NULL
;	NULL
Palombella	NULL
and	NULL
Maniatis	NULL
,	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Cancer	NULL
Institute	NULL
Grants	NULL
POL	NULL
CA49639-01A1	NULL
and	NULL
PO1	NULL
CA55164	NULL
,	NULL
American	NULL
Cancer	NULL
Society	NULL
Grant	NULL
IM-580	NULL
,	NULL
the	NULL
Sid	NULL
Richardson	NULL
Foundation	NULL
,	NULL
the	NULL
Bush	NULL
Leukemia	NULL
Fund	NULL
,	NULL
the	NULL
Ladies	NULL
Leukemia	NULL
League	NULL
of	NULL
Louisiana	NULL
,	NULL
the	NULL
Kleberg	NULL
Foundation	NULL
,	NULL
the	NULL
Wiley	NULL
Foundation	NULL
,	NULL
the	NULL
Anderson	NULL
Chair	NULL
for	NULL
Cancer	NULL
Treatment	NULL
and	NULL
Re-search	NULL
,	NULL
and	NULL
National	NULL
Cancer	NULL
Institute	NULL
Grant	NULL
CA16672	NULL
for	NULL
GCG	NULL
soft-ware	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenBank	NULL
``	NULL
/EMBL	NULL
Data	NULL
Bank	NULL
with	NULL
accession	NULL
number	NULL
(	NULL
s	NULL
)	NULL
L24442	NULL
.	NULL

{	NULL
To	NULL
whom	NULL
all	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
ad-dressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Hematology	NULL
,	NULL
Box	NULL
24	NULL
,	NULL
M.	NULL
D.	NULL
Anderson	NULL
Cancer	NULL
Center	NULL
,	NULL
1515	NULL
Holcombe	NULL
Blvd	NULL
.	NULL

,	NULL
Houston	NULL
,	NULL
TX	NULL
77030	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
713-792-8750	NULL
.	NULL

Fax	NULL
:	NULL
713-794-5868	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IRF-2	NULL
,	NULL
interferon	NULL
regulatory	NULL
factor	NULL
2	NULL
;	NULL
IRF-1	NULL
,	NULL
interferon	NULL
regulatory	NULL
factor	NULL
1	NULL
;	NULL
PRD1I	NULL
,	NULL
positive	NULL
regulatory	NULL
domain	NULL
I	NULL
;	NULL
ISG	NULL
,	NULL
interferon	NULL
stimulated	NULL
genes	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pairs	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
ISRE	NULL
,	NULL
interferon-stimulated	NULL
response	NULL
element	NULL
;	NULL
ISGF3	NULL
,	NULL
interferon-stimulated	NULL
gene	NULL
factor	NULL
3	NULL
;	NULL
ICSBP	NULL
,	NULL
interferon	NULL
consensus	NULL
se-quence-binding	NULL
protein	NULL
.	NULL

1992	NULL
)	NULL
.	NULL

Other	NULL
investigators	NULL
have	NULL
proposed	NULL
that	NULL
IRF-2	NULL
is	NULL
bound	NULL
to	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
type	NULL
I	NULL
interferon	NULL
genes	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
upon	NULL
exposure	NULL
of	NULL
cells	NULL
to	NULL
certain	NULL
stimuli	NULL
,	NULL
IRF-2	NULL
is	NULL
displaced	NULL
by	NULL
activated	NULL
interferon	NULL
regulatory	NULL
factor	NULL
1	NULL
(	NULL
IRF-1	NULL
)	NULL
,	NULL
which	NULL
initiates	NULL
the	NULL
interferon	NULL
gene	NULL
expression	NULL
(	NULL
Harada	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
1990	NULL
;	NULL
Watanabe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Palombella	NULL
and	NULL
Maniatis	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

These	NULL
stimuli	NULL
include	NULL
viruses	NULL
,	NULL
double-stranded	NULL
RNA	NULL
,	NULL
interferons	NULL
,	NULL
and	NULL
other	NULL
cytokines	NULL
or	NULL
inducers	NULL
of	NULL
certain	NULL
signal	NULL
transduction	NULL
pathways	NULL
,	NULL
e.g	NULL
.	NULL

interleukin-1	NULL
,	NULL
interleukin-6	NULL
,	NULL
leukemia	NULL
inhibitory	NULL
factor	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
prolactin	NULL
,	NULL
and	NULL
phorbol	NULL
ester	NULL
(	NULL
Miyamoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Fujita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Harada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
1990	NULL
;	NULL
Pine	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Yu-Lee	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Abdol-lahi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Watanabe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Harroch	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
by	NULL
Harada	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
that	NULL
the	NULL
level	NULL
of	NULL
IRF-2	NULL
mRNA	NULL
increases	NULL
4-6	NULL
h	NULL
after	NULL
induction	NULL
by	NULL
interferon-	NULL
and	NULL
6-9	NULL
h	NULL
after	NULL
induction	NULL
by	NULL
virus	NULL
,	NULL
as	NULL
detected	NULL
by	NULL
S1	NULL
mapping	NULL
analysis	NULL
.	NULL

The	NULL
increased	NULL
level	NULL
of	NULL
IRF-2	NULL
product	NULL
generated	NULL
after	NULL
induction	NULL
could	NULL
compete	NULL
with	NULL
IRF-1	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
PRDI	NULL
site	NULL
on	NULL
the	NULL
promoter	NULL
,	NULL
thus	NULL
terminating	NULL
interferon	NULL
production	NULL
(	NULL
Weissmann	NULL
and	NULL
Weber	NULL
,	NULL
1986	NULL
;	NULL
Harada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
1990	NULL
;	NULL
Goodbourn	NULL
,	NULL
1990	NULL
;	NULL
Palombella	NULL
and	NULL
Maniatis	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
cDNAs	NULL
for	NULL
mouse	NULL
and	NULL
human	NULL
IRF-2	NULL
have	NULL
been	NULL
isolated	NULL
by	NULL
Harada	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
and	NULL
Itoh	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
describe	NULL
the	NULL
isolation	NULL
of	NULL
genomic	NULL
DNA	NULL
encoding	NULL
human	NULL
IRF-2	NULL
,	NULL
and	NULL
the	NULL
identification	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
that	NULL
confers	NULL
expression	NULL
of	NULL
IRF-2	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
information	NULL
on	NULL
the	NULL
function	NULL
and	NULL
regulation	NULL
of	NULL
IRF-2	NULL
and	NULL
deepen	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
interferon	NULL
and	NULL
interferon-stimulated	NULL
gene	NULL
(	NULL
ISG	NULL
)	NULL
expression	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Screening	NULL
Genomic	NULL
Libraries-Genomic	NULL
DNA	NULL
libraries	NULL
derived	NULL
from	NULL
a	NULL
human	NULL
placenta	NULL
and	NULL
a	NULL
human	NULL
leukocyte	NULL
(	NULL
Clontech	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
)	NULL
were	NULL
plated	NULL
at	NULL
1	NULL
x	NULL
10°	NULL
phages/plate	NULL
(	NULL
20	NULL
x	NULL
150-mm	NULL
plates	NULL
)	NULL
.	NULL

Duplicate	NULL
nitrocellulose	NULL
filters	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
,	NULL
Inc.	NULL
)	NULL
containing	NULL
phage	NULL
DNA	NULL
were	NULL
hybridized	NULL
with	NULL
°P-IRF-2	NULL
cDNA	NULL
as	NULL
described	NULL
by	NULL
Cha	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
following	NULL
cDNA	NULL
fragments	NULL
were	NULL
prepared	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
and	NULL
used	NULL
as	NULL
additional	NULL
probes	NULL
for	NULL
screening	NULL
of	NULL
the	NULL
IRF-2	NULL
gene	NULL
.	NULL

For	NULL
detection	NULL
of	NULL
the	NULL
5'-end	NULL
of	NULL
the	NULL
ZRF-2	NULL
gene	NULL
,	NULL
the	NULL
sequence	NULL
+10	NULL
to	NULL
+102	NULL
base	NULL
pairs	NULL
(	NULL
bp	NULL
)	NULL
(	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
)	NULL
was	NULL
amplified	NULL
.	NULL

To	NULL
detect	NULL
exons	NULL
6	NULL
and	NULL
7	NULL
,	NULL
the	NULL
sequence	NULL
+530	NULL
to	NULL
+753	NULL
bp	NULL
was	NULL
prepared	NULL
.	NULL

The	NULL
putative	NULL
positive	NULL
clones	NULL
were	NULL
plaque	NULL
purified	NULL
,	NULL
digested	NULL
with	NULL
Sstl	NULL
(	NULL
for	NULL
the	NULL
placental	NULL
library	NULL
)	NULL
or	NULL
XhoI	NULL
(	NULL
for	NULL
the	NULL
leukocyte	NULL
library	NULL
)	NULL
,	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
pBluescript	NULL
II	NULL
SK-	NULL
vector	NULL
(	NULL
Stratagene	NULL
)	NULL
for	NULL
sequencing	NULL
(	NULL
Sambrook	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
was	NULL
determined	NULL
from	NULL
denatured	NULL
double-stranded	NULL
templates	NULL
by	NULL
the	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
using	NULL
Sequenase	NULL
(	NULL
United	NULL
States	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
(	NULL
Sanger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1977	NULL
;	NULL
Kraft	NULL
,	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
sequence	NULL
was	NULL
obtained	NULL
directly	NULL
from	NULL
the	NULL
phage	NULL
DNA	NULL
using	NULL
a	NULL
dsDNA	NULL
cycle	NULL
sequencing	NULL
system	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
were	NULL
stored	NULL
and	NULL
analyzed	NULL
using	NULL
GCG	NULL
software	NULL
(	NULL
University	NULL
of	NULL
Wisconsin	NULL
)	NULL
.	NULL

Cells-K562	NULL
cells	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
no	NULL
.	NULL

CCL	NULL
243	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
2	NULL
mm	NULL
L-glutamine	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
and	NULL
95	NULL
%	NULL
air	NULL
.	NULL

Induction	NULL
of	NULL
interferon-a	NULL
(	NULL
Intron	NULL
A	NULL
,	NULL
Schering	NULL
Corp.	NULL
)	NULL
and	NULL
interferon-y	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Genentech	NULL
Inc.	NULL
)	NULL
was	NULL
performed	NULL
at	NULL
1,000	NULL
units/ml	NULL
.	NULL

5279	NULL
5280	NULL
Primer	NULL
Extension	NULL
Analysis-A	NULL
40-nucleotide	NULL
primer	NULL
(	NULL
@	NULL
°GGTATAAGT-GTTGCTAGGGTGTGTGAAATGGAAATGAAAG®*	NULL
)	NULL
to	NULL
the	NULL
IRF-2	NULL
mRNA	NULL
was	NULL
5'-end-labeled	NULL
with	NULL
[	NULL
y-°°PJATP	NULL
(	NULL
>	NULL
6,000	NULL
Ci/mmol	NULL
,	NULL
New	NULL
England	NULL
Nuclear	NULL
)	NULL
by	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
primer	NULL
was	NULL
hybridized	NULL
to	NULL
60	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
and	NULL
subjected	NULL
to	NULL
primer	NULL
extension	NULL
with	NULL
400	NULL
units	NULL
of	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
RNase	NULL
H-	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Extension	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
sequencing	NULL
gel	NULL
in	NULL
parallel	NULL
with	NULL
a	NULL
*°S-labeled	NULL
sequencing	NULL
reaction	NULL
(	NULL
Sequenase	NULL
)	NULL
by	NULL
using	NULL
the	NULL
same	NULL
primer	NULL
on	NULL
a	NULL
IRF-2	NULL
genomic	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
5'-flanking	NULL
sequence	NULL
and	NULL
the	NULL
first	NULL
exon	NULL
subcloned	NULL
into	NULL
pBluescript	NULL
.	NULL

RNase	NULL
Protection	NULL
Assay-A	NULL
421-nucleotide	NULL
probe	NULL
from	NULL
the	NULL
5'-end	NULL
of	NULL
IRF-2	NULL
cDNA	NULL
was	NULL
labeled	NULL
with	NULL
[	NULL
«	NULL
-*°P	NULL
]	NULL
JUTP	NULL
by	NULL
using	NULL
T7	NULL
RNA	NULL
polymerase	NULL
from	NULL
the	NULL
RNA	NULL
transcription	NULL
kit	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
hybridized	NULL
to	NULL
5-10	NULL
ng	NULL
of	NULL
total	NULL
RNAs	NULL
in	NULL
a	NULL
hybridization	NULL
buffer	NULL
provided	NULL
in	NULL
a	NULL
ribo-nuclease	NULL
protection	NULL
assay	NULL
kit	NULL
(	NULL
Ambion	NULL
)	NULL
at	NULL
37-42	NULL
°C	NULL
for	NULL
16	NULL
h.	NULL
The	NULL
hybridized	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
a	NULL
RNase	NULL
A/RNase	NULL
Tl	NULL
mixture	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30-45	NULL
min	NULL
.	NULL

The	NULL
protected	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
sequencing	NULL
gel	NULL
in	NULL
parallel	NULL
with	NULL
*°P-la-beled	NULL
MspI	NULL
digests	NULL
of	NULL
pBR322	NULL
as	NULL
markers	NULL
.	NULL

Other	NULL
probes	NULL
used	NULL
in	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
were	NULL
IRF-1	NULL
,	NULL
356	NULL
nucleotides	NULL
from	NULL
the	NULL
5'-end	NULL
of	NULL
IRF-1	NULL
cDNA	NULL
and	NULL
actin	NULL
,	NULL
100	NULL
nucleotides	NULL
from	NULL
the	NULL
5'-end	NULL
of	NULL
actin	NULL
cDNA	NULL
.	NULL

Plasmid	NULL
DNA-Deleted	NULL
clones	NULL
in	NULL
pXP2	NULL
(	NULL
Nordeen	NULL
,	NULL
1988	NULL
)	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
PCR	NULL
products	NULL
.	NULL

These	NULL
products	NULL
were	NULL
phosphorylated	NULL
at	NULL
5'-end	NULL
by	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
filled	NULL
in	NULL
the	NULL
3	NULL
'	NULL
recess	NULL
DNA	NULL
ends	NULL
with	NULL
nucleotides	NULL
by	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
,	NULL
and	NULL
ligated	NULL
to	NULL
pXP2	NULL
at	NULL
the	NULL
Smal	NULL
site	NULL
.	NULL

Expres-gion	NULL
constructs	NULL
for	NULL
IRF-1	NULL
and	NULL
ISGF3y	NULL
were	NULL
prepared	NULL
by	NULL
ligating	NULL
2,000	NULL
bp	NULL
of	NULL
IRF-1	NULL
cDNA	NULL
insert	NULL
from	NULL
pUC18	NULL
to	NULL
pcDNA	NULL
I	NULL
(	NULL
Invitrogen	NULL
)	NULL
at	NULL
the	NULL
EcoRI	NULL
site	NULL
or	NULL
1,500	NULL
bp	NULL
of	NULL
ISGF3y	NULL
cDNA	NULL
from	NULL
pBluescript	NULL
SK-	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
David	NULL
Levy	NULL
)	NULL
to	NULL
pcDNA	NULL
I	NULL
at	NULL
the	NULL
Xhol/Xbal	NULL
sites	NULL
,	NULL
respectively	NULL
.	NULL

Transient	NULL
Expression	NULL
Analysis	NULL
with	NULL
Luciferase	NULL
Genes-DNAs	NULL
were	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
as	NULL
described	NULL
by	NULL
Sims	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
with	NULL
the	NULL
following	NULL
modifications	NULL
.	NULL

For	NULL
electroporation	NULL
,	NULL
pulses	NULL
were	NULL
applied	NULL
in	NULL
three	NULL
trains	NULL
with	NULL
15	NULL
pulses/train	NULL
.	NULL

Interferons	NULL
were	NULL
added	NULL
to	NULL
the	NULL
cell	NULL
culture	NULL
1	NULL
h	NULL
after	NULL
the	NULL
transfections	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
18-24	NULL
h	NULL
after	NULL
induction	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
(	NULL
in	NULL
arbitrary	NULL
light	NULL
units	NULL
)	NULL
.	NULL

Each	NULL
transfection	NULL
was	NULL
performed	NULL
in	NULL
duplicate	NULL
and	NULL
corrected	NULL
for	NULL
transfection	NULL
efficiency	NULL
by	NULL
cotransfecting	NULL
with	NULL
pSVB	NULL
(	NULL
a	NULL
B-galactosidase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
)	NULL
.	NULL

The	NULL
promoterless	NULL
vector	NULL
pXP2	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Others-Conditions	NULL
for	NULL
the	NULL
PCR	NULL
were	NULL
described	NULL
(	NULL
Cha	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Sims	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

All	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
on	NULL
a	NULL
Cruachem	NULL
PS-250	NULL
DNA	NULL
synthesizer	NULL
.	NULL

RESULTS	NULL
Isolation	NULL
of	NULL
Human	NULL
IRF-2	NULL
Genomic	NULL
Clones-To	NULL
study	NULL
the	NULL
genomic	NULL
organization	NULL
of	NULL
IRF-2	NULL
,	NULL
two	NULL
human	NULL
genomic	NULL
libraries	NULL
were	NULL
screened	NULL
with	NULL
P-labeled	NULL
full-length	NULL
IRF-2	NULL
cDNA	NULL
and	NULL
then	NULL
with	NULL
cDNA	NULL
fragments	NULL
harboring	NULL
different	NULL
parts	NULL
of	NULL
the	NULL
cDNA	NULL
sequence	NULL
.	NULL

Three	NULL
positive	NULL
clones	NULL
from	NULL
the	NULL
placental	NULL
library	NULL
(	NULL
containing	NULL
the	NULL
5'-flanking	NULL
region	NULL
,	NULL
exons	NULL
1-5	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
,	NULL
and	NULL
the	NULL
3'-flanking	NULL
region	NULL
)	NULL
and	NULL
one	NULL
clone	NULL
from	NULL
the	NULL
leukocyte	NULL
library	NULL
(	NULL
containing	NULL
exons	NULL
6	NULL
and	NULL
7	NULL
)	NULL
were	NULL
identified	NULL
from	NULL
2	NULL
x	NULL
10°	NULL
plaque-forming	NULL
units	NULL
and	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
pBluescript	NULL
vector	NULL
for	NULL
sequencing	NULL
.	NULL

Sequencing	NULL
was	NULL
performed	NULL
on	NULL
the	NULL
exons	NULL
and	NULL
the	NULL
exon-intron	NULL
boundaries	NULL
,	NULL
and	NULL
then	NULL
on	NULL
the	NULL
5'-	NULL
and	NULL
3'-flanking	NULL
sequences	NULL
.	NULL

The	NULL
complete	NULL
nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
exons	NULL
and	NULL
partial	NULL
sequences	NULL
of	NULL
introns	NULL
of	NULL
human	NULL
IRF-2	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
sequence	NULL
began	NULL
with	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
and	NULL
ended	NULL
at	NULL
a	NULL
site	NULL
210	NULL
nucleotides	NULL
3	NULL
'	NULL
to	NULL
the	NULL
end	NULL
of	NULL
the	NULL
published	NULL
cDNA	NULL
sequence	NULL
for	NULL
IRF-2	NULL
.	NULL

All	NULL
intron-exon	NULL
boundaries	NULL
conformed	NULL
to	NULL
known	NULL
splice	NULL
junction	NULL
consensus	NULL
sequences	NULL
(	NULL
Senapa-thy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
except	NULL
for	NULL
the	NULL
one	NULL
associated	NULL
with	NULL
the	NULL
seventh	NULL
intron	NULL
,	NULL
which	NULL
began	NULL
with	NULL
an	NULL
AG	NULL
dinucleotide	NULL
.	NULL

The	NULL
IRF-2	NULL
gene	NULL
consisted	NULL
of	NULL
nine	NULL
exons	NULL
that	NULL
ranged	NULL
in	NULL
size	NULL
from	NULL
47	NULL
nucleotides	NULL
(	NULL
exons	NULL
5	NULL
and	NULL
8	NULL
)	NULL
to	NULL
1,337	NULL
nucleotides	NULL
(	NULL
exon	NULL
9	NULL
)	NULL
.	NULL

The	NULL
first	NULL
exon	NULL
contained	NULL
only	NULL
a	NULL
5'-untranslated	NULL
sequence	NULL
;	NULL
the	NULL
initiating	NULL
ATG	NULL
codon	NULL
was	NULL
located	NULL
in	NULL
the	NULL
second	NULL
exon	NULL
,	NULL
where	NULL
it	NULL
was	NULL
preceded	NULL
by	NULL
a	NULL
six-nucleotide	NULL
5'-untranslated	NULL
sequence	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
IRF-2	NULL
continued	NULL
Human	NULL
Interferon	NULL
Regulatory	NULL
Factor	NULL
2	NULL
Gene	NULL
in	NULL
exons	NULL
3-8	NULL
,	NULL
and	NULL
a	NULL
termination	NULL
codon	NULL
(	NULL
TAA	NULL
)	NULL
was	NULL
encountered	NULL
in	NULL
exon	NULL
9	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
exons	NULL
confirmed	NULL
most	NULL
of	NULL
the	NULL
cDNA	NULL
sequences	NULL
published	NULL
by	NULL
Itoh	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

A	NULL
single	NULL
nucleotide	NULL
change	NULL
from	NULL
C	NULL
to	NULL
T	NULL
was	NULL
detected	NULL
in	NULL
exon	NULL
3	NULL
.	NULL

This	NULL
change	NULL
resulted	NULL
in	NULL
an	NULL
amino	NULL
acid	NULL
change	NULL
from	NULL
arginine	NULL
to	NULL
tryptophan	NULL
at	NULL
position	NULL
58	NULL
.	NULL

This	NULL
nucleotide	NULL
change	NULL
was	NULL
confirmed	NULL
by	NULL
sequencing	NULL
a	NULL
cDNA	NULL
clone	NULL
.	NULL

?	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
single	NULL
nucleotide	NULL
substitution	NULL
from	NULL
G	NULL
to	NULL
A	NULL
,	NULL
a	NULL
dinucleotide	NULL
TT	NULL
addition	NULL
,	NULL
and	NULL
a	NULL
dinucleotide	NULL
substitution	NULL
from	NULL
TC	NULL
to	NULL
AA	NULL
were	NULL
detected	NULL
in	NULL
exon	NULL
9	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
;	NULL
however	NULL
,	NULL
no	NULL
amino	NULL
acid	NULL
changes	NULL
were	NULL
involved	NULL
.	NULL

Chromosomal	NULL
Localization	NULL
of	NULL
the	NULL
Human	NULL
IRF-2	NULL
Gene-DNA	NULL
isolated	NULL
from	NULL
24	NULL
human-rodent	NULL
somatic	NULL
cell	NULL
hybrids	NULL
retaining	NULL
one	NULL
or	NULL
two	NULL
human	NULL
chromosomes	NULL
(	NULL
mapping	NULL
panel	NULL
no	NULL
.	NULL

2	NULL
from	NULL
Coriell	NULL
Cell	NULL
Repositories	NULL
)	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
chromosomal	NULL
location	NULL
of	NULL
the	NULL
IRF-2	NULL
gene	NULL
.	NULL

Two	NULL
sets	NULL
of	NULL
primers	NULL
were	NULL
selected	NULL
in	NULL
a	NULL
PCR	NULL
assay	NULL
.	NULL

One	NULL
set	NULL
of	NULL
primers	NULL
formed	NULL
a	NULL
single	NULL
product	NULL
(	NULL
365	NULL
bp	NULL
of	NULL
the	NULL
IRF-2	NULL
DNA	NULL
)	NULL
only	NULL
in	NULL
human	NULL
DNA	NULL
but	NULL
not	NULL
in	NULL
rodent	NULL
DNA	NULL
.	NULL

The	NULL
second	NULL
set	NULL
of	NULL
primers	NULL
forming	NULL
an	NULL
82-bp	NULL
product	NULL
in	NULL
DNA	NULL
from	NULL
all	NULL
species	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
to	NULL
ensure	NULL
equal	NULL
amount	NULL
of	NULL
DNA	NULL
in	NULL
each	NULL
sample	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
IRF-2	NULL
DNA	NULL
was	NULL
found	NULL
in	NULL
all	NULL
hybrids	NULL
containing	NULL
human	NULL
chromosome	NULL
4	NULL
.	NULL

Transcription	NULL
Initiation	NULL
Site	NULL
and	NULL
5'-Flanking	NULL
Region-The	NULL
5'-flanking	NULL
sequence	NULL
of	NULL
IRF-2	NULL
was	NULL
1.5	NULL
kilobases	NULL
in	NULL
length	NULL
just	NULL
before	NULL
the	NULL
first	NULL
exon	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

As	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
the	NULL
promoter	NULL
lacked	NULL
a	NULL
TATA	NULL
box	NULL
but	NULL
did	NULL
contain	NULL
a	NULL
putative	NULL
CAAT	NULL
box	NULL
at	NULL
position	NULL
-278	NULL
to	NULL
-274	NULL
,	NULL
Three	NULL
GC	NULL
boxes	NULL
(	NULL
GGGCGG	NULL
)	NULL
,	NULL
which	NULL
are	NULL
potential	NULL
Sp1l-binding	NULL
sites	NULL
,	NULL
were	NULL
located	NULL
beyond	NULL
the	NULL
3'-end	NULL
of	NULL
the	NULL
CAAT	NULL
box	NULL
and	NULL
one	NULL
Spl-binding	NULL
site	NULL
beyond	NULL
the	NULL
5'-end	NULL
.	NULL

Interspersed	NULL
with	NULL
the	NULL
GC	NULL
boxes	NULL
were	NULL
AARKGA	NULL
hexamers	NULL
(	NULL
where	NULL
R	NULL
=	NULL
A	NULL
or	NULL
G	NULL
and	NULL
K	NULL
=	NULL
G	NULL
or	NULL
T	NULL
)	NULL
and	NULL
GAAANN	NULL
sequences	NULL
,	NULL
which	NULL
are	NULL
commonly	NULL
found	NULL
in	NULL
type	NULL
I	NULL
interferon	NULL
gene	NULL
and	NULL
ISG	NULL
promoters	NULL
.	NULL

A	NULL
putative	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
3	NULL
``	NULL
to	NULL
the	NULL
CAAT	NULL
box	NULL
conformed	NULL
to	NULL
the	NULL
consensus	NULL
GGGRNNYYCC	NULL
(	NULL
where	NULL
R	NULL
=	NULL
A	NULL
or	NULL
G	NULL
,	NULL
Y	NULL
=C	NULL
or	NULL
T	NULL
,	NULL
and	NULL
N	NULL
=	NULL
any	NULL
nucleotide	NULL
;	NULL
Baeuerle	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

Primer	NULL
extension	NULL
analysis	NULL
of	NULL
the	NULL
IRF-2	NULL
gene	NULL
was	NULL
performed	NULL
to	NULL
determine	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

A	NULL
primer	NULL
was	NULL
synthesized	NULL
from	NULL
+50	NULL
to	NULL
+11	NULL
(	NULL
5	NULL
'	NULL
to	NULL
3	NULL
'	NULL
)	NULL
of	NULL
the	NULL
published	NULL
sequence	NULL
for	NULL
the	NULL
human	NULL
IRF-2	NULL
cDNA	NULL
(	NULL
Itoh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
primer	NULL
was	NULL
used	NULL
for	NULL
both	NULL
the	NULL
primer	NULL
extension	NULL
assays	NULL
and	NULL
a	NULL
sequencing	NULL
reaction	NULL
.	NULL

The	NULL
analysis	NULL
revealed	NULL
one	NULL
major	NULL
and	NULL
several	NULL
minor	NULL
initiation	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

All	NULL
minor	NULL
initiation	NULL
sites	NULL
were	NULL
further	NULL
upstream	NULL
from	NULL
the	NULL
major	NULL
site	NULL
.	NULL

Transcription	NULL
at	NULL
the	NULL
major	NULL
initiation	NULL
site	NULL
would	NULL
generate	NULL
a	NULL
transcript	NULL
that	NULL
would	NULL
include	NULL
10	NULL
nucleotides	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
IRF-2	NULL
cDNA	NULL
or	NULL
108	NULL
nucleotides	NULL
5	NULL
``	NULL
to	NULL
the	NULL
initiation	NULL
methionine	NULL
codon	NULL
.	NULL

Functional	NULL
Analysis	NULL
of	NULL
the	NULL
IRF-2	NULL
Promoter-In	NULL
order	NULL
to	NULL
study	NULL
the	NULL
function	NULL
of	NULL
IRF-2	NULL
promoter	NULL
,	NULL
the	NULL
fragment	NULL
containing	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
IRF-2	NULL
(	NULL
clone	NULL
-1555	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
promoterless	NULL
luciferase	NULL
reporter	NULL
gene	NULL
vector	NULL
pXP2	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
recombinant	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
and	NULL
tested	NULL
for	NULL
inducibility	NULL
with	NULL
both	NULL
interferon-y	NULL
and	NULL
interferon-a	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
(	NULL
clone	NULL
-1555	NULL
)	NULL
was	NULL
found	NULL
to	NULL
be	NULL
active	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
inducers	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
in	NULL
the	NULL
transient	NULL
transfection	NULL
assay	NULL
and	NULL
in	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
which	NULL
was	NULL
expected	NULL
since	NULL
four	NULL
potential	NULL
Spl-binding	NULL
sites	NULL
were	NULL
present	NULL
in	NULL
the	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
IRF-2	NULL
promoter	NULL
in	NULL
unstimulated	NULL
cells	NULL
was	NULL
studied	NULL
further	NULL
by	NULL
using	NULL
various	NULL
deleted	NULL
clones	NULL
of	NULL
the	NULL
IRF-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

When	NULL
one	NULL
of	NULL
four	NULL
Spl	NULL
sites	NULL
was	NULL
deleted	NULL
(	NULL
clone	NULL
-195	NULL
)	NULL
,	NULL
it	NULL
appeared	NULL
to	NULL
be	NULL
more	NULL
active	NULL
than	NULL
the	NULL
intact	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

However	NULL
,	NULL
if	NULL
all	NULL
four	NULL
Spl	NULL
sites	NULL
were	NULL
removed	NULL
(	NULL
clones	NULL
-85	NULL
,	NULL
-60	NULL
,	NULL
and	NULL
-20	NULL
)	NULL
,	NULL
the	NULL
recombinant	NULL
clones	NULL
showed	NULL
little	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
inducers	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
response	NULL
of	NULL
IRF	NULL
promoter	NULL
to	NULL
interferon-y	NULL
was	NULL
different	NULL
when	NULL
compared	NULL
2	NULL
Y	NULL
,	NULL
Cha	NULL
and	NULL
A.	NULL
Deisseroth	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

Fic	NULL
.	NULL

1	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
IRF-2	NULL
gene	NULL
and	NULL
the	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

Exon	NULL
sequences	NULL
are	NULL
in	NULL
uppercase	NULL
letters	NULL
;	NULL
intron	NULL
and	NULL
3'-flanking	NULL
sequences	NULL
are	NULL
in	NULL
lowercase	NULL
letters	NULL
.	NULL

The	NULL
first	NULL
nucleotide	NULL
corresponds	NULL
to	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

The	NULL
amino	NULL
acid	NULL
sequence	NULL
appears	NULL
below	NULL
the	NULL
nucleotide	NULL
sequence	NULL
for	NULL
each	NULL
exon	NULL
.	NULL

The	NULL
nucleotide	NULL
and	NULL
amino	NULL
acid	NULL
sequences	NULL
that	NULL
are	NULL
different	NULL
from	NULL
the	NULL
published	NULL
cDNA	NULL
sequence	NULL
of	NULL
IRF-2	NULL
are	NULL
underlined	NULL
.	NULL

Human	NULL
Interferon	NULL
Regulatory	NULL
Factor	NULL
2	NULL
Gene	NULL
5281	NULL
Exon	NULL
1	NULL
TGCGTTATTCAACTGACGGGCTTTCATTTCCATTTCACACACCCTAGCAACACTTATACCTTGCGGAATTGTATTGGTAG	NULL
Intron	NULL
1	NULL
Exon	NULL
2	NULL
CGTGAAAAAAGCACACTGAGAGgtaacatttt	NULL
.	NULL

.	NULL

.	NULL

tctccctaagGGCACCATGCCGGTGGAAAGGATGCGCATGCGCCc	NULL
MetProValGluArgNetArgMetArgPr	NULL
Intron	NULL
2	NULL
GTGGCTGGAGGAGCAGATAAACTCCAACACGATCCCGGGGCTCAAGTGGCTTAACAAGgtgagtgqgt	NULL
...	NULL
tttttttca	NULL
oTrpLeuGluGluGlnIleAsnSerAsnThrIleProGlyLeuLysTrpLeuAsnLys	NULL
Exon	NULL
3	NULL
gGAAAAGAAGATTTTTCAGATCCCCTGGATGCATGCGGCTAGACATGGGTGGGATGTGGAAAAAGATGCACCACTCTTTA	NULL
GluLysLysIlePheGlnIleProTrpMetHisAlaAlaArgHisGlyTrpAspValGluLysAspAlaProLeuPheA	NULL
Intron	NULL
3	NULL
GAAACTGGGCAATCCATACAGgtactaaaac	NULL
.	NULL

..	NULL
cttttqttagGMMCATCAACCAGGAGTAGATAMCﬂGATCCCA	NULL
rgAsnIrpAlalleHisThrG	NULL
lyLysHisGlnProGlyValAspLysProAspProl	NULL
AAACATGGAAGGCGAATTTCAGATGCGCCATGAATTCCTTGCCTGATA	NULL
TAAAAGCATAAAGAAA	NULL
ysThrTrpLysAlaAsnPheArgCysAlaMetAsnSerLeuProAspIleGluGluvValLysAspLysSerIleLysLys	NULL
Intron	NULL
4	NULL
GGAAATAATGCCTTCAGGGTCTACCGAATGCTGCCCCTATCAGAACGGCCTTCTAAGAAAGgtaaaggcatttacag	NULL
.	NULL

..	NULL
GlyAsnAsnAlaPheArgValTyrArgMet	NULL
LeuProLeuSerG	NULL
]	NULL
uaArgProSerLysLysG	NULL
Exon	NULL
5	NULL
Intron	NULL
5	NULL
Rxon	NULL
6	NULL
CAGAAAAAGAAGACAAAGTTAAGCACATCAAGgtaatcttgg	NULL
...	NULL
cctagCAaAGA	NULL
gttgccacagGAAAGAAACCAAAGA	NULL
!	NULL

1lyLysLysProlysThrGluLysGluAspLysValLysHisIleLys	NULL
GlnGl	NULL
ACCAGTTGAGTCATCTCTGGGGCTTAGTAATGGAGTAAGTGATCTTTCTCCTGAGTATGCGGTCCTGACTTCAACTATAA	NULL
uProValGluSerSerLeuGlyLeuSerAsnGlyValSerAspLeuSerProGluTyrAlaValLeuThrSerThrIleL	NULL
Intron	NULL
6	NULL
Exon	NULL
7	NULL
AAAATGAAGTGGATAGTACGGTGAACATCATAGgtaaactgtt	NULL
.	NULL

..	NULL
ttctttgaagTTGTAGGACAGTCCCATCTGGACA	NULL
ysAsnGluvalAspSerThrValAsnIle1leV	NULL
alValGlyGlnSerHisLeuAspS	NULL
$	NULL
GCAACATTGAGAATCAAGAGATTGTCACCAATCCGCCAGACATTTGCCAAGTTGTAGAGGTGACCACTGAGAGCGACGAG	NULL
eraAsnIleGluAsnGlnGlulleValThrAsnProProAspIleCysGlnValValGluvalThrThrGluSerAspGlu	NULL
Intron	NULL
7	NULL
CAGCCGGTCAGCATGAGCGAGCTCTACCCTCTGCAGATCTCCCCCGTGTCTTCCTATGCAGaggtaage	NULL
...	NULL
tctgagtc	NULL
GlnProValSerMetSerGluLeuTyrProLeuGlnIleSerProValSerSerTyrAlaG	NULL
Exon	NULL
8	NULL
Intron	NULL
8	NULL
Exon	NULL
9	NULL
agAAAGCGAAACGACTGATAGTGTGCCCAGCGATGAAGAGAGTGCCGAGgtaagccactg	NULL
.	NULL

..	NULL
ttcttgaaagGGACG6c	NULL
luSerGluThrThrAspSerValProSerAspGlugluSerAlaGlu	NULL
GlyArgP	NULL
roHisTrpArgLysArgAsnIleGluglyLysGlnTyrLeuSerAsnMetGlyThrArgGlySerTyrLeuLeuProGly	NULL
ATGGCGTCCTTCGTCACTTCCAACAAACCGGACCTCCAGGTCACCATCAAAGAGGAGAGCAATCCGGTGCCTTACAACAG	NULL
MetAlaSerPheValThrSerAsnLysProAspLeuglnValThrIleLysGluGluSerAsnProValProTyrAsnSe	NULL
CTCCTGSCCCCCTTITCAAGACCTCCCCCTTTCTTCCTCCATGACCCCAGCATCCAGCAGCAGTCGGCCAGACCGGGAGA	NULL
rSerTrpProProPheGlnAspLeuProLeuSerSerSerMetThrProAlaSerSerSerSerArgProAspArgGluT	NULL
CCCGGGCCAGCGTCATCAAGAAAACATCGGATATCACCCAGGCCCGCGTCAAGAGCTGTTAAgectctgactctccgogg	NULL
hrArgAlaServalIlleLysLysThrSerAspIleThrGlnAlaArgValLysSerCysEnd	NULL
TGGTTGTTGGGSCTTCTTGGCTTTGTTTTGTTGTITGTTIGTATTTTATTTTTITTCTCTCTGACACCTATTTTAGACAAA	NULL
TCTAAGGGAAAAAGCCTTGACAATAGAACATTGATTGCTGTGTCCAACTCCAGTACCTGGAGCTTCTCTTTAACTCAGGA	NULL
CTCCAGCCCATTGGTAGACGTGTGTTTCTAGAGCCTGCTGGATCTCCCAGGGCTACTCACTCAAGTTCAAGGACCAACAA	NULL
GGGCAGTGGAGGTGCTGCATTGCCTGCGGTCAAGGCCAGCAAGGTGGAGTGGATGCCTCAGAACGGACGAGATAATGTGA	NULL
ACTAGCTGGAATTTTTTATTCTTGTGAATATGTACATAGGCAGCACTAGCGACATTGCAGTCTGCTTCTGCACCTTATCT	NULL
TAAAGCACTTACAGATAGGCCTTCTTGTGATCTTGCTCTATCTCACAGCACACTCAGCACCCCCTTCTCTGCCCATTCCC	NULL
CAGCCTCTCTTCCTATCCCATCCCATCCCATCCCATCCCATCCCATCCCATCCCGCTCTTTTCCTACTTTTCCTTCCCTC	NULL
AAAGCTTCCATTCCACATCCGGAGGAGAAGAAGGAAATGAATTTCTCTACAGATGTCCCATTTTCAGACTGCTTTAAAAA	NULL
AAATCCTTCTAATCTGCTATGCTTGAATGCCACGCGGTACAAAGGAAAAAGTATCATGGAAATATTATGCAAATTCCCAG	NULL
ATTTGAAGACAAAAATACTCTAATTCTAACCAGAGCAAGCTTTTTTATTTTTTATACAGGGGAATATTTTATTCAAGGTA	NULL
AAATTCTAAATAAAATATAATTGTTTTTTATCTTITCTACAGCAAATTTATAATTTTAAGATTCCTTTTCTTGTTTATCA	NULL
GCAGTTGTTATTACATCCTTGTGGCACATTTTTTTTTTTAATTTTGTAAAGGTGAAAAAAGCTTTTATGAGCTCAAATAG	NULL
3	NULL
'	NULL
flanking	NULL
sequence	NULL
CAATCAGATTTTCCTGTGGAttgataataaatgaatatgatatatagttaaatttttaaggqggcatcactoctggctttg	NULL
tctgtgtctgctttaaaagagcatacacgqaataggactgacaaaggattgtttctttttgqggaccaaaatgttttcec	NULL
ttgttgaccacacagaaaceqgtqqgagqgttcttactogtqgagqcttcagattgacttcttctcttgagtye	NULL
with	NULL
the	NULL
basal	NULL
expression	NULL
of	NULL
IRF-2	NULL
promoter	NULL
.	NULL

A	NULL
2-fold	NULL
induction	NULL
by	NULL
interferon-y	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
clones	NULL
containing	NULL
Spl	NULL
sites	NULL
(	NULL
clones	NULL
-1555	NULL
and	NULL
-195	NULL
)	NULL
.	NULL

The	NULL
higher	NULL
levels	NULL
of	NULL
induction	NULL
which	NULL
appeared	NULL
in	NULL
the	NULL
clones	NULL
-85	NULL
and	NULL
-60	NULL
were	NULL
caused	NULL
by	NULL
the	NULL
decrease	NULL
of	NULL
the	NULL
basal	NULL
activity	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
Sp1	NULL
sites	NULL
in	NULL
these	NULL
clones	NULL
.	NULL

Clone	NULL
-20	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
the	NULL
interferon-y	NULL
treatment	NULL
.	NULL

The	NULL
promoter	NULL
was	NULL
also	NULL
inducible	NULL
with	NULL
interferon-	NULL
«	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
induction	NULL
by	NULL
interferon-y	NULL
was	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
interferon-a	NULL
.	NULL

The	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
interferon-y	NULL
interacts	NULL
with	NULL
the	NULL
sequence	NULL
(	NULL
s	NULL
)	NULL
present	NULL
in	NULL
clone	NULL
-60	NULL
but	NULL
absent	NULL
in	NULL
clone	NULL
-20	NULL
.	NULL

Induction	NULL
by	NULL
IRF-1-To	NULL
determine	NULL
the	NULL
possible	NULL
effects	NULL
of	NULL
other	NULL
interferon-inducible	NULL
proteins	NULL
on	NULL
the	NULL
IRF-2	NULL
promoter	NULL
,	NULL
the	NULL
IRF-2	NULL
promoter	NULL
construct	NULL
and	NULL
deleted	NULL
clones	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
IRF-2	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
containing	NULL
IRF-1	NULL
cDNA	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
or	NULL
ISGF37y	NULL
cDNA	NULL
.	NULL

The	NULL
basal	NULL
level	NULL
of	NULL
expression	NULL
in	NULL
each	NULL
clone	NULL
was	NULL
lower	NULL
in	NULL
Fig	NULL
.	NULL

64	NULL
than	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
since	NULL
less	NULL
proteins	NULL
were	NULL
used	NULL
to	NULL
perform	NULL
the	NULL
luciferase	NULL
activity	NULL
assay	NULL
.	NULL

IRF-1	NULL
was	NULL
found	NULL
to	NULL
strongly	NULL
enhance	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IRF-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

About	NULL
10-fold	NULL
induction	NULL
by	NULL
IRF-1	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
whole-length	NULL
promoter	NULL
(	NULL
clone	NULL
~1555	NULL
)	NULL
and	NULL
deleted	NULL
promoter	NULL
constructs	NULL
(	NULL
clones	NULL
-195	NULL
and	NULL
-85	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
induction	NULL
was	NULL
increased	NULL
when	NULL
1495	NULL
bp	NULL
from	NULL
5'-end	NULL
of	NULL
the	NULL
fragment	NULL
was	NULL
deleted	NULL
(	NULL
clone	NULL
-60	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
IRF-1	NULL
to	NULL
the	NULL
IRF-2	NULL
promoter	NULL
seems	NULL
to	NULL
be	NULL
unrelated	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Sp1	NULL
sites	NULL
since	NULL
the	NULL
highest	NULL
induction	NULL
was	NULL
5282	NULL
Human	NULL
Interferon	NULL
Regulatory	NULL
Factor	NULL
2	NULL
Gene	NULL
el	NULL
A	NULL
Chr	NULL
H	NULL
cmF	NULL
2	NULL
s	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
910	NULL
111213	NULL
141516171819	NULL
$	NULL
2122X	NULL
YH	NULL
C	NULL
M	NULL
go	NULL
-	NULL
MEW	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Chromosomal	NULL
localization	NULL
of	NULL
the	NULL
human	NULL
IRF-2	NULL
gene	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
and	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

The	NULL
size	NULL
of	NULL
each	NULL
product	NULL
was	NULL
given	NULL
on	NULL
the	NULL
left	NULL
side	NULL
of	NULL
the	NULL
figure	NULL
.	NULL

Genomic	NULL
DNA	NULL
from	NULL
human	NULL
cell	NULL
line	NULL
IMR-91	NULL
(	NULL
HH	NULL
)	NULL
,	NULL
Chinese	NULL
hamster	NULL
line	NULL
RJK88	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
mouse	NULL
line	NULL
3T6	NULL
(	NULL
M	NULL
)	NULL
was	NULL
used	NULL
as	NULL
positive	NULL
and	NULL
negative	NULL
controls	NULL
,	NULL
respectively	NULL
.	NULL

Primers	NULL
used	NULL
for	NULL
the	NULL
365-bp	NULL
product	NULL
were	NULL
CACCTGGCCAGTGATGCATTTTTAAAAAG	NULL
from	NULL
intron	NULL
8	NULL
and	NULL
from	NULL
the	NULL
IRF-2	NULL
cDNA	NULL
;	NULL
primers	NULL
for	NULL
the	NULL
82-bp	NULL
product	NULL
were	NULL
*AGTAACTTTTAGTTTTGCTCCT®	NULL
from	NULL
the	NULL
5'-flanking	NULL
region	NULL
and	NULL
AAGGTATAAGTGTTGCTAGGGTGTGTGAAA®®	NULL
from	NULL
the	NULL
IRF-2	NULL
cDNA	NULL
.	NULL

-1sss	NULL
GhaMOT	NULL
-1475	NULL
Ghani	NULL
-1398	NULL
-11s	NULL
aus	NULL
-1235	NULL
test	NULL
ws	NULL
.	NULL

=	NULL
-11ss	NULL
GhaAMRC	NULL
-1078	NULL
taktte	NULL
caviar	NULL
GAAAXN	NULL
~995	NULL
-s1s	NULL
AmRKGA	NULL
~835	NULL
_	NULL
anct	NULL
camont	NULL
cavort	NULL
-75s	NULL
GAAAMN	NULL
AbRKGA	NULL
~678	NULL
ectitc	NULL
caviar	NULL
Shamar	NULL
-ses	NULL
Amro	NULL
-s1s	NULL
cc	NULL
S2	NULL
.	NULL

~433	NULL
-253	NULL
w	NULL
‘	NULL
ShaAint	NULL
_	NULL
GamaIOt	NULL
|	NULL
CaAT_box	NULL
AnRKGA	NULL
-275	NULL
at	NULL
-195	NULL
(	NULL
regs	NULL
moan	NULL
s	NULL
386	NULL
.	NULL

_nzn__m	NULL
canal	NULL
cavont	NULL
&	NULL
-35	NULL
-	NULL
caggcaagcoggggagtaacttttagttttgetcerocormarrc	NULL
+10	NULL
B	NULL
0	NULL
aoe	NULL
-	NULL
aco	NULL
|	NULL
sco	NULL
.	NULL

meo	NULL
.	NULL

doo	NULL
.	NULL

taco	NULL
.	NULL

fado	NULL
.	NULL

tend	NULL
Cro	NULL
aon	NULL
abcess	NULL
conn	NULL
a	NULL
ime	NULL
cn	NULL
wss	NULL
CG	NULL
Hpalt	NULL
-	NULL
+	NULL
+	NULL
cose	NULL
GC	NULL
Box	NULL
T	NULL
«	NULL
cesces	NULL
NF4B	NULL
--	NULL
GwnN	NULL
e	NULL
«	NULL
-	NULL
a+	NULL
GMA	NULL
AARKGA	NULL
-	NULL
MRKGA	NULL
+	NULL
mANA	NULL
(	NULL
2-1555	NULL
--	NULL
-196	NULL
'Wuctwmse	NULL
«	NULL
0	NULL
{	NULL
m	NULL
20	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
JRF-2	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
locations	NULL
of	NULL
various	NULL
potential	NULL
regulatory	NULL
motifs	NULL
in	NULL
the	NULL
5'-flanking	NULL
sequence	NULL
are	NULL
marked	NULL
.	NULL

Nucleotides	NULL
are	NULL
numbered	NULL
negatively	NULL
to	NULL
the	NULL
left	NULL
of	NULL
the	NULL
sequence	NULL
,	NULL
with	NULL
nucleotide	NULL
1	NULL
corresponding	NULL
to	NULL
the	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
*	NULL
)	NULL
.	NULL

B	NULL
,	NULL
the	NULL
locations	NULL
of	NULL
CpG	NULL
islands	NULL
,	NULL
HpaII	NULL
sites	NULL
,	NULL
GC	NULL
boxes	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
,	NULL
GAAANN	NULL
sites	NULL
,	NULL
and	NULL
AARKGA	NULL
hexamers	NULL
were	NULL
determined	NULL
along	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IRF-2	NULL
using	NULL
the	NULL
program	NULL
``	NULL
mapplot	NULL
``	NULL
from	NULL
the	NULL
University	NULL
of	NULL
Wisconsin	NULL
sequence	NULL
analysis	NULL
software	NULL
package	NULL
.	NULL

The	NULL
restriction	NULL
enzyme	NULL
Hpall	NULL
recognizes	NULL
the	NULL
sequence	NULL
``	NULL
CCGG	NULL
``	NULL
.	NULL

GC	NULL
boxes	NULL
are	NULL
clustered	NULL
within	NULL
the	NULL
CpG	NULL
island	NULL
and	NULL
are	NULL
putative	NULL
Spl-binding	NULL
sites	NULL
.	NULL

The	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
was	NULL
indicated	NULL
as	NULL
the	NULL
beginning	NULL
of	NULL
mRNA	NULL
.	NULL

C	NULL
,	NULL
deleted	NULL
clones	NULL
were	NULL
prepared	NULL
by	NULL
subcloning	NULL
the	NULL
products	NULL
of	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
into	NULL
pXP2	NULL
vector	NULL
.	NULL

All	NULL
polymerase	NULL
chain	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
same	NULL
antisense	NULL
primer	NULL
(	NULL
'aggagcaaaactaaaagttact-*	NULL
'	NULL
)	NULL
and	NULL
different	NULL
sense	NULL
primers	NULL
.	NULL

The	NULL
sense	NULL
primer	NULL
for	NULL
clones	NULL
-1555	NULL
and	NULL
-195	NULL
was	NULL
the	NULL
T3	NULL
promoter	NULL
primer	NULL
from	NULL
the	NULL
pBluescript	NULL
SK-	NULL
vector	NULL
;	NULL
for	NULL
clone	NULL
-85	NULL
was	NULL
~S5opetcttcgcagtttectctectt©	NULL
``	NULL
;	NULL
for	NULL
clone	NULL
-60	NULL
was	NULL
~'gttttgetttcgatctg-gac~*	NULL
.	NULL

Clone	NULL
-20	NULL
was	NULL
made	NULL
by	NULL
annealing	NULL
an	NULL
oligonucleotide	NULL
complimentary	NULL
to	NULL
the	NULL
antisense	NULL
primer	NULL
.	NULL

G	NULL
A	NULL
T	NULL
#	NULL
C	NULL
S	NULL
%	NULL
140	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Determination	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

For	NULL
the	NULL
primer	NULL
extension	NULL
analysis	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
K562	NULL
cells	NULL
,	NULL
a	NULL
40-mer	NULL
oligonucleotide	NULL
complementary	NULL
to	NULL
nucleotides	NULL
21-60	NULL
of	NULL
IRF-2	NULL
(	NULL
exon	NULL
1	NULL
)	NULL
was	NULL
synthesized	NULL
and	NULL
used	NULL
to	NULL
prime	NULL
cDNA	NULL
synthesis	NULL
by	NULL
reverse	NULL
transcrip-tase	NULL
.	NULL

The	NULL
reaction	NULL
products	NULL
(	NULL
lane	NULL
S	NULL
)	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
denatured	NULL
sequencing	NULL
gel	NULL
with	NULL
the	NULL
corresponding	NULL
sequencing	NULL
reaction	NULL
run	NULL
on	NULL
the	NULL
left	NULL
(	NULL
lanes	NULL
G	NULL
,	NULL
A	NULL
,	NULL
T	NULL
,	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
major	NULL
transcription	NULL
initiation	NULL
site	NULL
is	NULL
marked	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

The	NULL
sequence	NULL
around	NULL
the	NULL
major	NULL
and	NULL
minor	NULL
sites	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
,	NULL
with	NULL
the	NULL
major	NULL
site	NULL
marked	NULL
as	NULL
*	NULL
.	NULL

observed	NULL
in	NULL
a	NULL
construct	NULL
containing	NULL
no	NULL
Sp1	NULL
sites	NULL
(	NULL
clone	NULL
-60	NULL
)	NULL
.	NULL

No	NULL
induction	NULL
was	NULL
observed	NULL
in	NULL
clone	NULL
-20	NULL
by	NULL
IRF-1	NULL
.	NULL

ISGF3qy	NULL
has	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
IRF	NULL
-2	NULL
promoter	NULL
by	NULL
the	NULL
transient	NULL
expression	NULL
assay	NULL
.	NULL
``	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
IRF-1	NULL
expression	NULL
vector	NULL
was	NULL
fully	NULL
func-tional	NULL
,	NULL
we	NULL
cotransfected	NULL
human	NULL
interferon-	NULL
promoter	NULL
in	NULL
pXP2	NULL
vector	NULL
with	NULL
IRF-1	NULL
cDNA	NULL
in	NULL
the	NULL
expression	NULL
vector	NULL
and	NULL
observed	NULL
the	NULL
level	NULL
of	NULL
luciferase	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
ex	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Interferon	NULL
inducibility	NULL
of	NULL
the	NULL
IRF-2	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
all	NULL
clones	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
were	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
and	NULL
treated	NULL
with	NULL
interferon-y	NULL
(	NULL
+IFN-y	NULL
)	NULL
or	NULL
without	NULL
any	NULL
inducers	NULL
(	NULL
-IFN-y	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
24	NULL
h	NULL
after	NULL
induction	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
promoterless	NULL
vector	NULL
pXP2	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
(	NULL
ctrl	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
was	NULL
repeated	NULL
on	NULL
three	NULL
separated	NULL
occa-sions	NULL
.	NULL

The	NULL
fold	NULL
of	NULL
induction	NULL
by	NULL
interferons	NULL
in	NULL
each	NULL
test	NULL
was	NULL
similar	NULL
.	NULL

B	NULL
,	NULL
folds	NULL
of	NULL
induction	NULL
by	NULL
interferon-y	NULL
were	NULL
determined	NULL
from	NULL
A	NULL
with	NULL
the	NULL
level	NULL
of	NULL
luciferase	NULL
after	NULL
interferon-y	NULL
induction	NULL
divided	NULL
by	NULL
the	NULL
level	NULL
before	NULL
induction	NULL
.	NULL

C	NULL
,	NULL
the	NULL
full-length	NULL
promoter	NULL
construct	NULL
(	NULL
clone	NULL
-1555	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
and	NULL
treated	NULL
with	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
,	NULL
interferon-	NULL
«	NULL
(	NULL
IFN-	NULL
«	NULL
)	NULL
,	NULL
or	NULL
without	NULL
any	NULL
treatment	NULL
(	NULL
No	NULL
T	NULL
)	NULL
.	NULL

The	NULL
promoterless	NULL
vector	NULL
pXP2	NULL
(	NULL
XP2	NULL
Vector	NULL
)	NULL
showed	NULL
negligible	NULL
luciferase	NULL
activity	NULL
.	NULL

Human	NULL
Interferon	NULL
Regulatory	NULL
Factor	NULL
2	NULL
Gene	NULL
Luciferase	NULL
Activity	NULL
(	NULL
Thousands	NULL
)	NULL
Folds	NULL
of	NULL
Induction	NULL
by	NULL
Luciferase	NULL
Activity	NULL
{	NULL
Thousands	NULL
}	NULL
45	NULL
35	NULL
25	NULL
05	NULL
5283	NULL
A	NULL
|	NULL
»	NULL
-IFN-y	NULL
+IFN-y	NULL
ctrl	NULL
XP2	NULL
Vector	NULL
No	NULL
T	NULL
IFNY	NULL
IFN-	NULL
a	NULL
5284	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Induction	NULL
of	NULL
IRF-2	NULL
by	NULL
IRF-1	NULL
protein	NULL
.	NULL

A	NULL
,	NULL
the	NULL
conditions	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
were	NULL
the	NULL
same	NULL
as	NULL
those	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
except	NULL
that	NULL
IRF-1	NULL
cDNA	NULL
in	NULL
an	NULL
expression	NULL
vector	NULL
(	NULL
pcDNA	NULL
I	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
each	NULL
clone	NULL
(	NULL
+1	NULL
)	NULL
.	NULL

Parental	NULL
vectors	NULL
(	NULL
pXP2	NULL
and	NULL
peDNA	NULL
I	NULL
)	NULL
were	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
(	NULL
Vectors	NULL
)	NULL
.	NULL

No	NULL
interferons	NULL
were	NULL
added	NULL
.	NULL

B	NULL
,	NULL
folds	NULL
of	NULL
induction	NULL
were	NULL
determined	NULL
from	NULL
A	NULL
with	NULL
level	NULL
of	NULL
luciferase	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
overexpressed	NULL
IRF-1	NULL
divided	NULL
by	NULL
the	NULL
activity	NULL
without	NULL
addition	NULL
of	NULL
IRF-1	NULL
.	NULL

C	NULL
,	NULL
either	NULL
peDNA	NULL
I	NULL
vector	NULL
or	NULL
IRF-1	NULL
in	NULL
peDNA	NULL
I	NULL
(	NULL
+1	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
interferon-B	NULL
promoter	NULL
(	NULL
-274	NULL
to	NULL
+15	NULL
bp	NULL
)	NULL
in	NULL
pXP2	NULL
(	NULL
IFN-8	NULL
)	NULL
(	NULL
Sims	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Parental	NULL
vector	NULL
(	NULL
pXP2	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Human	NULL
Interferon	NULL
Regulatory	NULL
Factor	NULL
2	NULL
Gene	NULL
Luciferase	NULL
Activity	NULL
Folds	NULL
of	NULL
induction	NULL
by	NULL
IRF-1	NULL
{	NULL
Thousands	NULL
)	NULL
Luolfermse	NULL
Activity	NULL
190	NULL
160	NULL
170	NULL
160	NULL
150	NULL
140	NULL
130	NULL
120	NULL
no	NULL
100	NULL
70	NULL
40	NULL
A	NULL
GX	NULL
e	NULL
xo	NULL
5	NULL
e	NULL
‘	NULL
0	NULL
.	NULL

e	NULL
e	NULL
xX	NULL
e	NULL
e	NULL
lete	NULL
*	NULL
s	NULL
e	NULL
e	NULL
lete	NULL
le	NULL
Resist	NULL
y	NULL
EH	NULL
b	NULL
Rss	NULL
Vectors	NULL
~1555+1	NULL
-195+1	NULL
1555	NULL
95	NULL
-1555	NULL
~195	NULL
-85	NULL
60	NULL
~20	NULL
Xp2	NULL
Fig	NULL
«	NULL
pCONA	NULL
pressed	NULL
IRF-1	NULL
activated	NULL
the	NULL
expression	NULL
of	NULL
interferon-	NULL
pro-	NULL
-	NULL
RNA	NULL
level	NULL
by	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
pre-	NULL
moter	NULL
.	NULL

pared	NULL
from	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
IRF-1	NULL
cDNA	NULL
in	NULL
an	NULL
expres-	NULL
The	NULL
induction	NULL
of	NULL
IRF-2	NULL
by	NULL
IRF-1	NULL
was	NULL
further	NULL
tested	NULL
at	NULL
the	NULL
-	NULL
sion	NULL
vector	NULL
.	NULL

IRF-1	NULL
and	NULL
IRF-2	NULL
cDNA	NULL
probes	NULL
were	NULL
used	NULL
to	NULL
detect	NULL
Human	NULL
Interferon	NULL
Regulatory	NULL
Factor	NULL
2	NULL
Gene	NULL
1	NULL
2	NULL
3	NULL
#	NULL
-	NULL
<	NULL
IRF-2	NULL
<	NULL
IRF-1	NULL
@	NULL
B	NULL
u	NULL
-	NULL
<	NULL
ACTIN	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Induction	NULL
of	NULL
endogenous	NULL
IRF-2	NULL
mRNA	NULL
by	NULL
overexpressed	NULL
IRF-1	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
K562	NULL
cells	NULL
transfected	NULL
with	NULL
parental	NULL
vectors	NULL
(	NULL
pXP2	NULL
and	NULL
peDNA	NULL
I	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
with	NULL
IRF-1	NULL
in	NULL
the	NULL
expression	NULL
vector	NULL
peDNA	NULL
I	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
tRNA	NULL
was	NULL
used	NULL
as	NULL
the	NULL
source	NULL
of	NULL
RNA	NULL
to	NULL
serve	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
for	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
probes	NULL
used	NULL
in	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
were	NULL
IRF-1	NULL
,	NULL
IRF-2	NULL
,	NULL
and	NULL
actin	NULL
cDNAs	NULL
.	NULL

the	NULL
expression	NULL
of	NULL
the	NULL
IRF-1	NULL
mRNA	NULL
and	NULL
the	NULL
endogenous	NULL
IRF-2	NULL
mRNA	NULL
,	NULL
respectively	NULL
.	NULL

An	NULL
actin	NULL
cDNA	NULL
probe	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
total	NULL
RNA	NULL
used	NULL
in	NULL
each	NULL
sample	NULL
.	NULL

IRF-2	NULL
was	NULL
detected	NULL
in	NULL
unstimulated	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
parental	NULL
expression	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

No	NULL
expression	NULL
of	NULL
IRF-1	NULL
was	NULL
observed	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

When	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
IRF-1	NULL
cDNA	NULL
in	NULL
the	NULL
expression	NULL
vector	NULL
,	NULL
a	NULL
high	NULL
level	NULL
of	NULL
IRF-1	NULL
mRNA	NULL
expression	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
overexpressed	NULL
IRF-1	NULL
is	NULL
active	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
by	NULL
which	NULL
it	NULL
activates	NULL
the	NULL
expression	NULL
of	NULL
interferon-B	NULL
promoter	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
IRF-2	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
also	NULL
increased	NULL
when	NULL
comparing	NULL
with	NULL
the	NULL
basal	NULL
level	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
those	NULL
of	NULL
the	NULL
transient	NULL
transfection	NULL
assay	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
IRF-1	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
IRF-2	NULL
at	NULL
the	NULL
transcription	NULL
level	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
isolated	NULL
the	NULL
genomic	NULL
clones	NULL
for	NULL
IRF-2	NULL
,	NULL
mapped	NULL
the	NULL
IRF-2	NULL
gene	NULL
to	NULL
human	NULL
chromosome	NULL
4	NULL
,	NULL
and	NULL
determined	NULL
the	NULL
site	NULL
for	NULL
transcription	NULL
initiation	NULL
and	NULL
intron-exon	NULL
5285	NULL
*	NULL
IRF-2	NULL
MPVERMRMRPWLEEQINSNTIPGLKWLNKEKKIFQIPWMHAARKHGWDVEK	NULL
50	NULL
Ue	NULL
LLL	NULL
ULN	NULL
bbe	NULL
1D	NULL
.	NULL

+d	NULL
[	NULL
11	NULL
IRF-1	NULL
MPITWMRMRPWLEMQINSNQIPGLIWINKEEMILEIPWKHAAKKHGWDINK	NULL
50	NULL
#	NULL
#	NULL
IRF-2	NULL
DAPLFRNWAIHTGKHQPGVDKPDPKTWKANFRCAMNSLPDIEEVKDKSIK	NULL
100	NULL
L	NULL
WOO	NULL
WOOT	NULL
+++	NULL
+L	NULL
+	NULL
>	NULL
IRF-1	NULL
DACLFRSWAIHTGRYKAGEKEPDPKTWKANFRCAMNSLPDIEEVKDQSRN	NULL
100	NULL
#	NULL
#	NULL
#	NULL
IRF-2	NULL
KGNNAFRVYRHLPLSERPSKKQKKPKTBKEDKVKHIKQEPVESSIG	NULL
LSN	NULL
149	NULL
AHL	NULL
_	NULL
:	NULL
lid	NULL
.|..	NULL
f	NULL
+	NULL
IRF-1	NULL
KGSSAVRVYWPLTKNQRKERKSKSSRDAKSKAKRKSCGDSSPMFSD	NULL
150	NULL
#	NULL
#	NULL
#	NULL
IRF-2	NULL
GV	NULL
.	NULL

SDLSPEYAVLTSTIKNEVDSTVNIIYVGQSHLDSNIENQEIVTNPP	NULL
197	NULL
[	NULL
f	NULL
«	NULL
1	NULL
(	NULL
%	NULL
111	NULL
IRF-1	NULL
GLSSSTLPDDHSSYT	NULL
...	NULL
...	NULL
VPGYMQDLEVEQA	NULL
.	NULL

LTPALSPCAVSSTLP	NULL
193	NULL
#	NULL
IRF-2	NULL
oxcowzmzsozowsuszupmxspvssuzsmo	NULL
.	NULL

SVPSDE	NULL
243	NULL
1	NULL
-o-l	NULL
lle	NULL
<	NULL
=	NULL
>	NULL
{	NULL
:	NULL
]	NULL
|:4	NULL
]	NULL
A	NULL
]	NULL
<	NULL
+	NULL
]	NULL
.	NULL

%	NULL
~	NULL
:	NULL
]	NULL
~	NULL
]	NULL
pwHtpvEvyppsr	NULL
.	NULL

...	NULL
..	NULL
SDLYNPQVSPHPSTSEA	NULL
’	NULL
I	NULL
'	NULL
I	NULL
‘	NULL
DEDEEGKLPEDI	NULL
*	NULL
IRF-1	NULL
®	NULL
IRF-2	NULL
ESAEGRPHHRKRNIEGKQYLSN	NULL
HGTRGSYLLPGKASFVTSNKPDIQVTI	NULL
292	NULL
IRF-1	NULL
HKLLEQSEWQPTNVDGKGYLLNEPGVQPTSVYGDF	NULL
...	NULL
..	NULL
SCKEEPEIDS	NULL
282	NULL
IRF-2	NULL
KEESNPVPYNSSHPPFQDLP	NULL
.	NULL

LSSSMTPASSSSRPDRETRASVIKKTS	NULL
339	NULL
Bil	NULL
[	NULL
.	NULL
]	NULL

tf	NULL
fax	NULL
«	NULL
f	NULL
+s	NULL
IRF-1	NULL
PGQDIGLSIQRVFTDIKNHDATWIDSLLTPVRLPSIQAIPCAP	NULL
325	NULL
#	NULL
IRF-2	NULL
DTTQARVKSC	NULL
349	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Aligned	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
human	NULL
IRF-2	NULL
and	NULL
IRF-1	NULL
.	NULL

The	NULL
homologies	NULL
were	NULL
determined	NULL
with	NULL
the	NULL
University	NULL
of	NULL
Wisconsin	NULL
GCG	NULL
program	NULL
BESTFIT	NULL
.	NULL

The	NULL
splice	NULL
sites	NULL
,	NULL
where	NULL
the	NULL
exonic	NULL
sequences	NULL
were	NULL
interrupted	NULL
by	NULL
introns	NULL
,	NULL
are	NULL
marked	NULL
by	NULL
an	NULL
asterisk	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
IRF-2	NULL
sequence	NULL
and	NULL
underneath	NULL
the	NULL
IRF-1	NULL
sequence	NULL
.	NULL

Single-letter	NULL
amino	NULL
acid	NULL
codes	NULL
are	NULL
shown	NULL
.	NULL

Sequences	NULL
were	NULL
numbered	NULL
on	NULL
the	NULL
right	NULL
of	NULL
each	NULL
line	NULL
.	NULL

An	NULL
underlined	NULL
amino	NULL
acid	NULL
indicates	NULL
that	NULL
the	NULL
coding	NULL
triplet	NULL
for	NULL
that	NULL
amino	NULL
acid	NULL
was	NULL
interrupted	NULL
between	NULL
the	NULL
first	NULL
and	NULL
second	NULL
nucleotides	NULL
by	NULL
an	NULL
intron	NULL
.	NULL

Identical	NULL
amino	NULL
acids	NULL
between	NULL
two	NULL
sequences	NULL
were	NULL
labeled	NULL
as	NULL
``	NULL
!	NULL

``	NULL
,	NULL
conservative	NULL
substituted	NULL
amino	NULL
acids	NULL
were	NULL
labeled	NULL
as	NULL
``	NULL
.	NULL
``	NULL

and	NULL
``	NULL
:	NULL
.	NULL
``	NULL

boundary	NULL
.	NULL

We	NULL
also	NULL
provided	NULL
direct	NULL
evidence	NULL
for	NULL
the	NULL
interaction	NULL
between	NULL
IRF-1	NULL
and	NULL
IRF-2	NULL
using	NULL
a	NULL
transient	NULL
expression	NULL
assay	NULL
and	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

This	NULL
information	NULL
is	NULL
necessary	NULL
to	NULL
begin	NULL
a	NULL
detailed	NULL
analysis	NULL
of	NULL
the	NULL
regulatory	NULL
mechanisms	NULL
of	NULL
IRF-2	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
IRF-2	NULL
gene	NULL
consists	NULL
of	NULL
nine	NULL
exons	NULL
and	NULL
eight	NULL
introns	NULL
,	NULL
whereas	NULL
human	NULL
IRF-1	NULL
contains	NULL
10	NULL
exons	NULL
and	NULL
nine	NULL
introns	NULL
(	NULL
Cha	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
exon	NULL
organization	NULL
of	NULL
the	NULL
human	NULL
IRF-2	NULL
and	NULL
IRF-1	NULL
genes	NULL
is	NULL
very	NULL
similar	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
it	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
exon	NULL
phase	NULL
is	NULL
identical	NULL
in	NULL
the	NULL
corresponding	NULL
introns	NULL
of	NULL
human	NULL
IRF-2	NULL
and	NULL
IRF-1	NULL
.	NULL

In	NULL
both	NULL
genes	NULL
,	NULL
the	NULL
coding	NULL
triplet	NULL
is	NULL
interrupted	NULL
between	NULL
the	NULL
first	NULL
and	NULL
second	NULL
nucleotides	NULL
in	NULL
introns	NULL
3	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Introns	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
have	NULL
no	NULL
interruption	NULL
in	NULL
the	NULL
coding	NULL
triplet	NULL
.	NULL

The	NULL
size	NULL
of	NULL
each	NULL
exon	NULL
is	NULL
almost	NULL
identical	NULL
for	NULL
both	NULL
the	NULL
IRF-2	NULL
and	NULL
IRF-1	NULL
genes	NULL
,	NULL
except	NULL
the	NULL
ninth	NULL
exon	NULL
of	NULL
IRF-2	NULL
is	NULL
longer	NULL
and	NULL
covers	NULL
both	NULL
the	NULL
ninth	NULL
and	NULL
tenth	NULL
exons	NULL
of	NULL
IRF-1	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
indicate	NULL
that	NULL
IRF-1	NULL
and	NULL
IRF-2	NULL
were	NULL
derived	NULL
from	NULL
a	NULL
common	NULL
primordial	NULL
gene	NULL
.	NULL

The	NULL
5'-flanking	NULL
regions	NULL
of	NULL
human	NULL
IRF-2	NULL
and	NULL
IRF-1	NULL
are	NULL
very	NULL
similar	NULL
.	NULL

Both	NULL
regions	NULL
contain	NULL
a	NULL
putative	NULL
CAAT	NULL
box	NULL
and	NULL
lack	NULL
a	NULL
TATA	NULL
box	NULL
.	NULL

Multiple	NULL
transcription	NULL
initiation	NULL
sites	NULL
were	NULL
found	NULL
in	NULL
IRF-2	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
and	NULL
in	NULL
IRF-1	NULL
by	NULL
primer	NULL
extension	NULL
analysis	NULL
,	NULL
as	NULL
described	NULL
by	NULL
Sims	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Numerous	NULL
AARKGA	NULL
hexamers	NULL
and	NULL
GAAANN	NULL
sequences	NULL
were	NULL
found	NULL
throughout	NULL
the	NULL
5'-flanking	NULL
sequences	NULL
of	NULL
IRF-1	NULL
(	NULL
Sims	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
IRF-2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Both	NULL
promoters	NULL
seem	NULL
to	NULL
be	NULL
constitutively	NULL
expressed	NULL
and	NULL
are	NULL
inducible	NULL
with	NULL
interferon-	NULL
«	NULL
and	NULL
interferon-y	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
5286	NULL
Inducers	NULL
IFN	NULL
_	NULL
Virus	NULL
Prolactin	NULL
IL-6	NULL
m	NULL
:	NULL
+	NULL
iRF-2	NULL
Phorbol	NULL
ester|	NULL
-	NULL
1*	NULL
\\	NULL
/	NULL
ISG	NULL
_	NULL
IFN	NULL
Fic	NULL
.	NULL

9	NULL
.	NULL

Model	NULL
of	NULL
interaction	NULL
and	NULL
function	NULL
of	NULL
IRF-1	NULL
and	NULL
IRF-2	NULL
.	NULL

Induction	NULL
and	NULL
repression	NULL
were	NULL
marked	NULL
as	NULL
``	NULL
+	NULL
``	NULL
and	NULL
``	NULL
-	NULL
``	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
abbreviations	NULL
used	NULL
were	NULL
:	NULL
IL-6	NULL
,	NULL
interleukin-6	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
LIF	NULL
,	NULL
leukemia	NULL
inhibitory	NULL
factor	NULL
;	NULL
IFN	NULL
,	NULL
interferons	NULL
;	NULL
ISG	NULL
,	NULL
interferon-stimulated	NULL
genes	NULL
.	NULL

transient	NULL
expression	NULL
assays	NULL
.	NULL

The	NULL
response	NULL
to	NULL
interferon-y	NULL
in	NULL
both	NULL
promoters	NULL
is	NULL
stronger	NULL
than	NULL
the	NULL
response	NULL
to	NULL
the	NULL
inter-feron-a	NULL
«	NULL
a	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
for	NULL
IRF-2	NULL
;	NULL
Sims	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
,	NULL
for	NULL
IRF-1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
all	NULL
the	NULL
similarities	NULL
,	NULL
there	NULL
are	NULL
some	NULL
differences	NULL
between	NULL
the	NULL
5'-flanking	NULL
regions	NULL
of	NULL
IRF-2	NULL
and	NULL
IRF-1	NULL
.	NULL

First	NULL
,	NULL
the	NULL
locations	NULL
of	NULL
the	NULL
CAAT	NULL
box	NULL
are	NULL
different	NULL
between	NULL
IRF-2	NULL
(	NULL
-278	NULL
to	NULL
-274	NULL
)	NULL
and	NULL
IRF-1	NULL
(	NULL
-97	NULL
to	NULL
-91	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
eight	NULL
putative	NULL
Sp1	NULL
sites	NULL
and	NULL
three	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
were	NULL
found	NULL
in	NULL
IRF-1	NULL
,	NULL
whereas	NULL
only	NULL
four	NULL
Spl	NULL
sites	NULL
and	NULL
one	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
were	NULL
found	NULL
in	NULL
IRF-2	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
induction	NULL
by	NULL
interferons	NULL
was	NULL
much	NULL
greater	NULL
in	NULL
the	NULL
IRF-1	NULL
promoter	NULL
than	NULL
in	NULL
the	NULL
IRF-2	NULL
promoter	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
the	NULL
transient	NULL
transfection	NULL
assays	NULL
.	NULL

These	NULL
differences	NULL
could	NULL
explain	NULL
the	NULL
ways	NULL
these	NULL
genes	NULL
are	NULL
regulated	NULL
in	NULL
the	NULL
cells	NULL
and	NULL
their	NULL
different	NULL
responses	NULL
to	NULL
interferons	NULL
.	NULL

A	NULL
truncated	NULL
form	NULL
of	NULL
IRF-2	NULL
(	NULL
PRDI-BFi	NULL
)	NULL
was	NULL
reported	NULL
by	NULL
both	NULL
Whiteside	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
and	NULL
Palombella	NULL
and	NULL
Maniatis	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
cDNA	NULL
for	NULL
PRDI-BFi	NULL
was	NULL
not	NULL
cloned	NULL
,	NULL
Palombella	NULL
and	NULL
Maniatis	NULL
(	NULL
1992	NULL
)	NULL
deleted	NULL
185	NULL
amino	NULL
acids	NULL
from	NULL
the	NULL
C-ter-minal	NULL
of	NULL
IRF-2	NULL
and	NULL
tested	NULL
the	NULL
truncated	NULL
gene	NULL
to	NULL
show	NULL
that	NULL
it	NULL
behaved	NULL
as	NULL
did	NULL
PRDI-BFi	NULL
in	NULL
terms	NULL
of	NULL
molecular	NULL
mass	NULL
and	NULL
mobility	NULL
on	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

If	NULL
the	NULL
site	NULL
of	NULL
truncation	NULL
for	NULL
PRDI-BFi	NULL
that	NULL
they	NULL
proposed	NULL
is	NULL
correct	NULL
,	NULL
it	NULL
would	NULL
be	NULL
located	NULL
inside	NULL
exon	NULL
6	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
the	NULL
production	NULL
of	NULL
PRDI-BFi	NULL
is	NULL
a	NULL
result	NULL
of	NULL
an	NULL
alternative	NULL
splicing	NULL
.	NULL

As	NULL
Palombella	NULL
and	NULL
Maniatis	NULL
(	NULL
1992	NULL
)	NULL
suggested	NULL
,	NULL
PRDI-BFi	NULL
is	NULL
probably	NULL
a	NULL
product	NULL
of	NULL
proteolysis	NULL
in	NULL
post-translational	NULL
modification	NULL
of	NULL
IRF	NULL
-2	NULL
.	NULL

It	NULL
was	NULL
reported	NULL
by	NULL
other	NULL
investigators	NULL
that	NULL
IRF-1	NULL
is	NULL
activated	NULL
first	NULL
when	NULL
cells	NULL
are	NULL
exposed	NULL
to	NULL
virus	NULL
or	NULL
interferons	NULL
and	NULL
that	NULL
IRF-2	NULL
expression	NULL
is	NULL
increased	NULL
4-6	NULL
h	NULL
later	NULL
(	NULL
Miyamoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Fujita	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Harada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
1990	NULL
;	NULL
Pine	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Watanabe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Direct	NULL
evidence	NULL
for	NULL
an	NULL
inductive	NULL
effect	NULL
of	NULL
IRF-1	NULL
on	NULL
the	NULL
IRF-2	NULL
promoter	NULL
has	NULL
not	NULL
been	NULL
shown	NULL
before	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
results	NULL
presented	NULL
in	NULL
Figs	NULL
.	NULL

5A	NULL
and	NULL
6A	NULL
,	NULL
the	NULL
putative	NULL
binding	NULL
site	NULL
(	NULL
s	NULL
)	NULL
of	NULL
IRF-1	NULL
to	NULL
the	NULL
IRF-2	NULL
promoter	NULL
and	NULL
responsive	NULL
domain	NULL
of	NULL
the	NULL
IRF-2	NULL
promoter	NULL
to	NULL
interferon	NULL
treatments	NULL
appear	NULL
to	NULL
be	NULL
located	NULL
in	NULL
40	NULL
nucleotides	NULL
(	NULL
-60	NULL
to	NULL
-20	NULL
bp	NULL
)	NULL
5	NULL
to	NULL
the	NULL
major	NULL
transcriptional	NULL
initiation	NULL
site	NULL
of	NULL
IRF-2	NULL
.	NULL

A	NULL
potential	NULL
binding	NULL
site	NULL
found	NULL
in	NULL
interferon	NULL
and	NULL
interferon-inducible	NULL
gene	NULL
promoters	NULL
(	NULL
the	NULL
GAAANN	NULL
site	NULL
)	NULL
is	NULL
found	NULL
in	NULL
this	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
GAAANN	NULL
sequence	NULL
could	NULL
be	NULL
associated	NULL
with	NULL
the	NULL
IRF-1-binding	NULL
site	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
IRF-2	NULL
.	NULL

However	NULL
,	NULL
no	NULL
obvious	NULL
binding	NULL
pattern	NULL
was	NULL
observed	NULL
on	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL
``	NULL

It	NULL
was	NULL
reported	NULL
by	NULL
Sims	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
that	NULL
the	NULL
IRF-1	NULL
promoter	NULL
is	NULL
not	NULL
induced	NULL
by	NULL
IRF-1	NULL
protein	NULL
.	NULL

As	NULL
proposed	NULL
on	NULL
a	NULL
model	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
IRF-1	NULL
is	NULL
activated	NULL
by	NULL
inducers	NULL
and	NULL
activated	NULL
IRF-1	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
interferons	NULL
and	NULL
interferon-inducible	NULL
genes	NULL
.	NULL

To	NULL
break	NULL
the	NULL
loop	NULL
of	NULL
IRF-1	NULL
and	NULL
interferon	NULL
interaction	NULL
,	NULL
IRF-1	NULL
activates	NULL
the	NULL
expression	NULL
of	NULL
IRF-2	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
IRF-2	NULL
competes	NULL
with	NULL
IRF-1	NULL
for	NULL
the	NULL
binding	NULL
on	NULL
the	NULL
interferon	NULL
promoter	NULL
and	NULL
terminates	NULL
the	NULL
expression	NULL
of	NULL
interferons	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
activated	NULL
IRF-1	NULL
on	NULL
the	NULL
IRF-2	NULL
promoter	NULL
did	NULL
not	NULL
require	NULL
the	NULL
presence	NULL
of	NULL
interferons	NULL
since	NULL
the	NULL
genes	NULL
for	NULL
both	NULL
Human	NULL
Interferon	NULL
Regulatory	NULL
Factor	NULL
2	NULL
Gene	NULL
interferon-a	NULL
and	NULL
interferon-B	NULL
were	NULL
deleted	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
Diaz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

The	NULL
core	NULL
sequence	NULL
of	NULL
PRDI	NULL
in	NULL
the	NULL
interferon-§	NULL
promoter	NULL
(	NULL
GAAANN	NULL
)	NULL
is	NULL
found	NULL
in	NULL
the	NULL
interferon-stimulated	NULL
response	NULL
element	NULL
(	NULL
ISRE	NULL
)	NULL
of	NULL
interferon-inducible	NULL
genes	NULL
(	NULL
Naf	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

It	NULL
was	NULL
reported	NULL
that	NULL
IRF-1	NULL
(	NULL
ISGF-2	NULL
)	NULL
could	NULL
bind	NULL
to	NULL
the	NULL
ISRE	NULL
(	NULL
Pine	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Naf	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Besides	NULL
IRF-1	NULL
,	NULL
two	NULL
other	NULL
proteins	NULL
binding	NULL
to	NULL
ISRE	NULL
of	NULL
the	NULL
interferon-inducible	NULL
genes	NULL
,	NULL
interferon-stimulated	NULL
gene	NULL
factor	NULL
3	NULL
(	NULL
ISGF3	NULL
)	NULL
and	NULL
interferon	NULL
consensus	NULL
se-quence-binding	NULL
protein	NULL
(	NULL
ICSBP	NULL
)	NULL
,	NULL
have	NULL
been	NULL
characterized	NULL
recently	NULL
(	NULL
Levy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Driggers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Fu	NULL
,	NULL
1992	NULL
;	NULL
Fu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Schindler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19922	NULL
,	NULL
1992b	NULL
;	NULL
Kanno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Nelson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

ISGF3	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
that	NULL
mediates	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
a	NULL
set	NULL
of	NULL
genes	NULL
immediately	NULL
after	NULL
interferon-	NULL
«	NULL
treatment	NULL
(	NULL
Fu	NULL
,	NULL
1992	NULL
;	NULL
Fu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Schindler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

ISGF3	NULL
is	NULL
a	NULL
multicomponent	NULL
complex	NULL
in	NULL
which	NULL
three	NULL
subunits	NULL
(	NULL
ISGF3	NULL
«	NULL
)	NULL
associate	NULL
with	NULL
a	NULL
DNA-binding	NULL
domain	NULL
(	NULL
ISGF3y	NULL
)	NULL
(	NULL
Levy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Schindler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992a	NULL
)	NULL
.	NULL

Unlike	NULL
IRF-1	NULL
,	NULL
ISGF3qy	NULL
seems	NULL
to	NULL
have	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
IRF-1	NULL
and	NULL
IRF-2	NULL
.	NULL
``	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
different	NULL
activation	NULL
pathways	NULL
are	NULL
required	NULL
for	NULL
the	NULL
IRF	NULL
family	NULL
and	NULL
ISGF3	NULL
.	NULL

ICSBP	NULL
is	NULL
another	NULL
member	NULL
of	NULL
IRF	NULL
family	NULL
which	NULL
exhibits	NULL
a	NULL
similar	NULL
inhibitory	NULL
function	NULL
with	NULL
respect	NULL
to	NULL
IRF-2	NULL
and	NULL
sequence	NULL
homologies	NULL
with	NULL
IRF-2	NULL
(	NULL
Driggers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kanno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Nelson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
IRF-1	NULL
can	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
ICSBP	NULL
as	NULL
is	NULL
the	NULL
case	NULL
for	NULL
IRF-2	NULL
.	NULL

The	NULL
complete	NULL
function	NULL
of	NULL
IRF-2	NULL
in	NULL
cells	NULL
is	NULL
not	NULL
clearly	NULL
under-stood	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
data	NULL
presented	NULL
by	NULL
Harada	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
and	NULL
Palombella	NULL
and	NULL
Maniatis	NULL
(	NULL
1992	NULL
)	NULL
,	NULL
IRF-2	NULL
may	NULL
inhibit	NULL
the	NULL
IRF-1-dependent	NULL
activation	NULL
of	NULL
the	NULL
interferon-B	NULL
promoter	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
IRF-1/IRF-2	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
(	NULL
Palombella	NULL
and	NULL
Maniatis	NULL
,	NULL
1992	NULL
;	NULL
Harada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Harada	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
showed	NULL
that	NULL
overexpression	NULL
of	NULL
IRF-2	NULL
resulted	NULL
in	NULL
a	NULL
transformed	NULL
phenotype	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
and	NULL
tumorigenicity	NULL
in	NULL
nude	NULL
mice	NULL
.	NULL

It	NULL
would	NULL
be	NULL
interesting	NULL
to	NULL
know	NULL
whether	NULL
IRF-2	NULL
performs	NULL
these	NULL
functions	NULL
directly	NULL
through	NULL
its	NULL
regulation	NULL
on	NULL
the	NULL
interferon	NULL
genes	NULL
or	NULL
by	NULL
regulation	NULL
of	NULL
IRF-1	NULL
and	NULL
other	NULL
interferon-inducible	NULL
genes	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
studying	NULL
the	NULL
interaction	NULL
of	NULL
IRF-2	NULL
with	NULL
other	NULL
interferon-inducible	NULL
proteins	NULL
and	NULL
trying	NULL
to	NULL
understand	NULL
the	NULL
complete	NULL
regulation	NULL
and	NULL
functions	NULL
of	NULL
IRF-2	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Donald	NULL
Chang	NULL
for	NULL
radio-frequency	NULL
wave	NULL
electroporation	NULL
apparatus	NULL
,	NULL
David	NULL
Levy	NULL
for	NULL
ISGF3y	NULL
cDNA	NULL
,	NULL
Xiang	NULL
Ming	NULL
Fang	NULL
,	NULL
Laurel	NULL
Huston	NULL
,	NULL
Mary	NULL
E.	NULL
Brown	NULL
,	NULL
and	NULL
Daniel	NULL
Quigley	NULL
for	NULL
their	NULL
technical	NULL
supports	NULL
,	NULL
and	NULL
Rosemarie	NULL
Lauzon	NULL
for	NULL
her	NULL
expert	NULL
editorial	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
Abdollahi	NULL
,	NULL
A.	NULL
,	NULL
Lord	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Hoffman-Liebermann	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Liebermann	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

2	NULL
,	NULL
401-407	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072	NULL
,	NULL
63-80	NULL
Cha	NULL
,	NULL
Y.	NULL
,	NULL
Sims	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Romine	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Kaufmann	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Deisseroth	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
DNA	NULL
Cell	NULL
Biol	NULL
.	NULL

11	NULL
,	NULL
605-611	NULL
Diaz	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
Ziemin	NULL
,	NULL
S.	NULL
,	NULL
Beau	NULL
,	NULL
M.	NULL
M.	NULL
L.	NULL
,	NULL
Pitha	NULL
,	NULL
P.	NULL
,	NULL
Smith	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Chilote	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
and	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
5259-5263	NULL
Driggers	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Ennist	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Gleason	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Mak	NULL
,	NULL
W.	NULL
,	NULL
Mark	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Levi	NULL
,	NULL
B.	NULL
,	NULL
Flanagan	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Appella	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Ozato	NULL
,	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
3743-3747	NULL
Fu	NULL
,	NULL
X.	NULL
Y	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
323-335	NULL
Fu	NULL
,	NULL
X.	NULL
Y.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Improta	NULL
,	NULL
T.	NULL
,	NULL
Aebersold	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
7840-7843	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Reis	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
Watanabe	NULL
,	NULL
N.	NULL
,	NULL
Kimura	NULL
,	NULL
Y.	NULL
,	NULL
Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Vilcek	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
9936-9940	NULL
Goodbourn	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Cancer	NULL
Biol	NULL
.	NULL

1	NULL
,	NULL
89-95	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
Kimura	NULL
,	NULL
Y.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Furia	NULL
,	NULL
A.	NULL
,	NULL
Miyata	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
729-739	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Kitagawa	NULL
,	NULL
M.	NULL
,	NULL
Tanaka	NULL
,	NULL
N.	NULL
,	NULL
Yamamoto	NULL
,	NULL
H.	NULL
,	NULL
Harada	NULL
,	NULL
K.	NULL
,	NULL
Ishihara	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
259	NULL
,	NULL
971-974	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Willison	NULL
,	NULL
K.	NULL
,	NULL
Sakakibara	NULL
,	NULL
J.	NULL
,	NULL
Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
63	NULL
,	NULL
303-312	NULL
Harroch	NULL
,	NULL
S.	NULL
,	NULL
Gothelf	NULL
,	NULL
Y.	NULL
,	NULL
Watanabe	NULL
,	NULL
N.	NULL
,	NULL
Revel	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Chebath	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
9092-9097	NULL
Itoh	NULL
,	NULL
S.	NULL
,	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Mimura	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
8372	NULL
Kanno	NULL
,	NULL
Y.	NULL
,	NULL
Kozak	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Driggers	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Ennist	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Gleason	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Human	NULL
Interferon	NULL
Regulatory	NULL
Factor	NULL
2	NULL
Gene	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Ozato	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3951-3963	NULL
Kraft	NULL
,	NULL
R.	NULL
,	NULL
Tardiff	NULL
,	NULL
J.	NULL
,	NULL
Krauter	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
and	NULL
Leinwand	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
BioTechniques	NULL
6	NULL
,	NULL
544-549	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Kessler	NULL
,	NULL
d.	NULL
S.	NULL
,	NULL
Pine	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1362-1371	NULL
Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Kimura	NULL
,	NULL
Y.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Sudo	NULL
,	NULL
Y.	NULL
,	NULL
Miyata	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
54	NULL
,	NULL
903-913	NULL
Naf	NULL
,	NULL
D.	NULL
,	NULL
Hardin	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Weissmann	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
1369-1373	NULL
Nelson	NULL
,	NULL
N.	NULL
,	NULL
Marks	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
Driggers	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
and	NULL
Ozato	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
588-599	NULL
Nordeen	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
BioTechniques	NULL
6	NULL
,	NULL
454-458	NULL
Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
3325-3336	NULL
Pine	NULL
,	NULL
R.	NULL
,	NULL
Decker	NULL
,	NULL
T.	NULL
,	NULL
Kessler	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Levy	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2448-2457	NULL
Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
a	NULL
Laboratory	NULL
Manual	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
5287	NULL
Sanger	NULL
,	NULL
F.	NULL
,	NULL
Nicklen	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Coulson	NULL
,	NULL
A.	NULL
R.	NULL
(	NULL
1977	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

74	NULL
,	NULL
5463-5467	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Prezioso	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
19922	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
809-812	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Fu	NULL
,	NULL
X-Y	NULL
.	NULL

,	NULL
Improta	NULL
,	NULL
T.	NULL
,	NULL
Aebersold	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1992b	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
7836-7839	NULL
Senapathy	NULL
,	NULL
P.	NULL
,	NULL
Shapiro	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Harris	NULL
,	NULL
N.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

183	NULL
,	NULL
252-278	NULL
Sims	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
Cha	NULL
,	NULL
Y.	NULL
,	NULL
Romine	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Gao	NULL
,	NULL
P.	NULL
Q.	NULL
,	NULL
Gottlieb	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Deisseroth	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
690-702	NULL
Watanabe	NULL
,	NULL
N.	NULL
,	NULL
Sakakibara	NULL
,	NULL
J.	NULL
,	NULL
Hovanessian	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Fujita	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
4421-4428	NULL
Weissmann	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Weber	NULL
,	NULL
H.	NULL
(	NULL
1986	NULL
)	NULL
Prog	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

33	NULL
,	NULL
251-300	NULL
Whiteside	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Visvanathan	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
and	NULL
Goodbourn	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
1531-1538	NULL
Yu-Lee	NULL
,	NULL
L.	NULL
Y.	NULL
,	NULL
Hrachovy	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Stevens	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
Schwarz	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
3087-3094	NULL

